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Recent efforts, directed towards the syntheses of complex natural products 
have pointed out the need for a variety of versatile chiral synthetic 
intermediates, so-called “chiral building blocks” [1]. Easy available ones are 
prepared from chiral materials produced in nature including carbohydrates, 
amino acids, hydroxy acids, terpenes etc. Among them, carbohydrates are 
ideally suited as synthons for natural products as the combination of the 
natural chirality and inherent topology of a cyclic sugar derivative provides a 
high degree of regio- and stereocontrol for the systematic functionalization of 
predetermined sites in the molecules. Such carbohydrate-derived ‘chiral 
templates’ can be further modified and eventually integrated into the structural 
framework of the synthetic target [2]. 
6-Substituted 5,6-dihydro-α-pyrones, so-called α,β-unsaturated δ-lactones (Fig. 
1) are widely distributed in, both, plants and fungi and have been isolated from 
thirteen families of plants and twenty fungal species. They possess a diverse 
range of biological activities and have been reported as plant growth inhibitors, 
insect antifeedants, antifungal and antitumour agents [3]. In some instances 
they have been used as intermediates for the synthesis of other natural 












































Fig. 1. Representative examples of some 6-substituted 5,6-dihydro-α-pyrones;    
(-)-argentilactone (1a), (-)-massoilactone (1b), (+)-osmundalactone (1c), (+)-
goniothalamine (1d), (+)-anamarine (1e) and callystatin A (1f). 
 
Inspite of their rather simple structure, these lactones possess a complete 
diverse nature. The side chain at C-6 (pyran nomenclature is followed in 
numbering) may be saturated (e.g. 1b) , unsaturated (e.g. 1a, 1d) or highly 
functionalized (e.g. 1e, 1f), containing additional chiral centers. C-5 can also 
be substituted (e.g. 1c) and thus presenting a challenge to the chemist with 
respect to their asymmetric syntheses. 
Retrosynthetically it can be envisioned (Scheme 1) that the intermediate, 
alcohol D, can be a common precursor for the synthesis of all types of such 
α,β-unsaturated δ-lactones. The lactones containing double bond between C7-
C8 can be constructed via a Wittig reaction between aldehyde E and a suitable 
 3
phosphonium salt. The saturated side chain on the other hand can be 
introduced through the nucleophilic displacement of some leaving group (e.g. 
halide, mesyl, or tosyl group) prepared from the alcohol D which itself can be 
constructed via a ring opening reaction on the benzylidene acetal B. As it 
becomes obvious from Scheme 1, methyl-α-D-glucopyranoside (2) can be 
















































Scheme 1. Retrosynthetic analysis for the synthesis of 6-alkyl and 6-alkenyl 
5,6-dihydro-α-pyrones. 
 
Another important feature of these α,β-unsaturated δ-lactones is the presence 
of an asymmetric centre at C-6 which can be either S or R, as natural products 
with either configurations exist in nature. Application of carbohydrate 
 4
templates in the total synthesis of natural products suffers, if L-sugars are 
demanding.  
This thesis demonstrates the asymmetric total syntheses of some 
representative examples from this class of natural product such as S-(+)-
argentilactone (11), R-(-)-massoilactone (1b), (+)-osmundalactone (1c), and 
R-(-)-argentilactone (1a), starting from carbohydrate templates. Both, S- and 
R-configurations were achieved from the same starting material i.e. D-glucose.  
 
On the other hand, a variety of examples for regio- and stereoselective 
transformations of 2,3-anhydropentoses (and in some cases 3,4-
anhydropentoses), delivering a series of chiral heterocyclic systems and a 
selected set of 4-substituted 2,3-anhydrosugar derivatives for bioassays have 




































B. Results and Discussion 
 
I. Total Synthesis  of S-(+)-Argentilactone (11), the Non-natural 
Enantiomer of Argentilactone (1a) 
 
Argentilactone (1a), an α,β-unsaturated δ-lactone, was originally isolated in 
1977 from the rhizomes of Aristolochia argentina Gris [6]. This compound is the 
major constituent of the essential oil and hexane extract of Annona 
haematantha [7] and also present in the methanolic extract of the leaves of 
Chorisia crispiflora [8]. The biological studies on 1a have revealed high 
antileishmanial [7] and cytotoxic activity against P-388 mouse leukemia cells 
[8]. Moreover, it can also be used as starting material for the synthesis of 
interesting pheromones [9]. These features prompted some research groups to 
undertake the total synthesis of argentilactone [10-13]. 
As carbohydrates and their derivatives possess several attributes which make 
them ideal precursors for enantiopure syntheses [2a], this was one  of the 
purposes of this thesis to design an efficient strategy to synthesize α,β-
unsaturated δ-lactones in an enantioselective way and in good yield which can 
be applied to the majority of the natural products belonging to this class of 
compounds. According to the retroanalysis (Scheme 1), methyl-α-D-
glucopyranoside (2) can be a potential starting material for the synthesis of 
argentilactone and other δ-lactones. Unfortunately, the stereochemistry at C-6 
 6
(pyran numbering) of 1a is R which requires a sugar from the L-series. 
Nevertheless, to confirm the absolute stereochemistry of 1a, and to test any 
biological activity, we describe here an asymmetric total synthesis of S-(+)-
argentilactone 11. 
Thus, under the modifications suggested by Holder and Fraser-Reid [14] for 
Evan’s reaction, 2 was efficiently converted into methyl-4,6-di-O-benzylidene-α-
D-glucopyranoside (3) in 90 % yield. The spectroscopic data ware found to be 
exactly identical with those, already reported. The vicinal diol in 3 was now 
ready to undergo 2,3-dideoxygenation and we applied, firstly, the conditions 
described by Garegg and Samualsson [15a]. The reaction was not, however, 
clean and an impure product with a low yield was obtained. As a second choice, 
we found that iodoform/imidazole/triphenylphosphine in toluene [15b] is an 
excellent reagent to produce 4 (87% yield) as nice crystals (m.p. 122 oC 
(ethanol)). At this stage, we wanted to open the benzylidene ring in a regio- and 
stereoselective manner. Surprisingly the known oxidative[16] and reductive [17] 
ring opening methods gave a mixture of products in low yield. Alternatively, it 
was decided to open the acetal 3 under Hanessian’s conditions (NBS, BaCO3 in 
refluxing CCl4) to produce methyl 6-bromo-6-deoxy-4-O-benzoyl-α-D-
glucopyranoside (12) [18] followed by the 2,3-dideoxygenation with the above 
mentioned system (CHI3/PPh3/imidazol). The bromo-olefine 13, so obtained, 
was reacted with triphenylphosphine [19] to prepare the phosphonium salt 14, 




























Scheme 2. Opening of benzylidene ring according to reference [18]. Reagents 
and conditions: a) NBS, BaCO3, reflux for 1 h in CCl4, b) PPh3, imidazole, CHI3, 
toluene, reflux for 1 h, c) PPh3, toluene, 90 oC for 6 days. 
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Under N2 at –40oC 
Stirring at rt for 6 days 
Stirring at rt for 6 days 
Refluxing for 5 hr 
-10oC 
Refluxing 
Under N2 at 0oC 
 
In a further attempt, we hydrolysed the benzylidene ring by the I2/MeOH [20] 
to get the diol 5, but the desired product was formed in about 10% yield only.  
 8
Stirring the olefin acetal 4 in methanol containing catalytic amounts of p-
toluenesulfonic acid monohydrate [21] gave, at –10 oC, the hydrolysed product 
5 in good yield. It was, however, observed that at higher temperature (even at 
room temperature) a considerable amount of furandiol 17 was also formed. 
Various attempts to open the benzylidene ring are summarised in Table 1 and 
it was shown that AlCl3/tBuOOH in CH2Cl2 at –40 0C was the best method for 





















6 R1 = OBz, R2 = OH














Scheme 3. Total synthesis of S-(+) argentilactone (11) starting from methyl-α-
D-glucopyranoside (2). Reagents and conditions: a) α,α−dimethoxytoluene, p-
toluenesulfonic acid, DMF, reflux under reduced pressure, 1h, 97%; b) PPh3, 
imidazole, CHI3, toluene, reflux, 2h, 87%; c) AlCl3, t-BuOOH, CH2Cl2, -40 oC, 
30 min, 80%; d) benzoyl chloride, pyridine, 0 oC, 8h, 90%; e) MsCl, pyridine, 5 
oC, 4h, 95%; f) lithium triethylborohydride, THF, 12h, 70%; g) oxalyl chloride, 
DMSO, -40 oC, Et3N, 1h, 90%; h) C6H13PPh3Br, n-BuLi, 80%; i) aq H2O2, MoO3 
and then Ac2O, pyridine, 70%. 
 
 9
Selective protection of the diol 5 at primary position with benzoyl chloride at 0 
oC and mesylation of the secondary alcohol was carried out easily to produce 7 
in 90 % yield over two steps. The mesyl group was displaced with 
Superhydride  (lithium triethylborohydride, 1 M solution in THF). Presence of a 
CH2 signal at δ = 26 ppm in the 13C NMR (GASPE) and a multiplet around δ = 2 
ppm in 1H NMR spectrum confirmed the deoxygenation at C-4 of the alcohol 8. 
Swern oxidation of 8 generated the aldehyde 9. Wittig reaction of 
hexyltriphenylphosphonium bromide with the aldehyde 9 produced the double 
bond between C-7 and C-8 in compound 10. The cis stereochemistry of the 
double bond was indicated by the low coupling constant (J = 10.3 Hz). Finally, 
10 was oxidized at the anomeric position with aqueous H2O2 in the presence of 
a catalytic amount of MoO3 [22] to generate the target argentilactone 11 in 
∼ 30% overall yield from 2. All spectroscopic data correlated with the reported 
natural product 1a except the optical rotation ([α]D = +21, c =1, EtOH) which 










II.1. Massoilactone (1b) 
 
Pheromones, allomones and kairomones are chemical substances that control the 
inter- and intraspecific behavior of a variety of bioorganisms e.g. flies, moths, 
cockroaches, beetles, weevils, rootworms, ants and bees, etc [23]. (-)-
Massoilactone (1b) is the allomone of the two species of formicine ants of the 
genus camponotus, collected in Western Australia [24]. In 1937, Abe isolated (-)-
massoilactone (1b) for the first time from the bark oil of Cryptocarya massoia, 
used for many centuries as a constituent of native medicine [25]. It has also been 
isolated from jasmine flowers [26] as well as from cane molasses (in which it is a 
flavor component) [27]. Its gross structure was confirmed by the synthesis of its 
racemic material [28] and the assignment of the absolute stereochemistry, as R, 
was confirmed by comparative ORD studies [29] and syntheses of the non-natural 
(6S) enantiomer [30].  In addition to various methods [28,30,31] for the synthesis 
of 1b, a number of asymmetric syntheses have been reported in the literature, 
based on the chiral pool as starting material [32-34], chiral induction [35-37,39] 
or chromatographic resolution of diastereomeric derivatives of the lactone 
precursor [38].  
An efficient strategy involving the use of R-epichlorohydrin (18) as chiral pool 
material was reported, where 18 undergoes successive alkylations to generate 19. 
Methoxy carbonylation of the acetylenic end followed by reduction with Lindlar 
 11
catalyst and lactonization produced 1b [32] (Scheme 4, eq. 1). A similar approach 
was adopted by Kjær [33] who reacted the tert-butyl propiolate ion with a chiral 
epoxide, obtained from D-glutamic acid through a series of steps. In another 
approach chiral starting material was used for the asymmetric synthesis of 1b 
using a Baeyer-Villiger oxidation of cyclopentanone 22, obtained by epoxidation 
and rearrangement of the enone 21 [34] (Scheme 4, eq. 2).  
Enzymatic resolution (porcine pancreatic lipase, PPL) of racemic open chain 3,5-
syn dihydroxy ester 23 resulted in the lactone 24 [35] which was transformed to 
1b via dehydration by POCl3 in CH2Cl2 (Scheme 4, eq. 3). Use of Baker’s yeast to 
reduce keto esters has been studied extensively. F. Bannett et al. [36] reduced β-
ketoester 25 to enantiopure β-hydroxyester 26 by using baker’s yeast. The 
hydroxyester 26 underwent a series of reactions to generate lactone 27 which can 
be finally dehydrated to 1b by using POCl3 in pyridine (Scheme 4, eq. 4). 
Recently, P. V. Ramachandram et al. [37] have reported an asymmetric synthesis 
of 1b via an asymmetric allylboration-esterification-cyclization strategy. The key 
reaction is a ring-closing metathesis reaction on the di-olefine 28  in the presence 
of Grubbs’ catayst (Scheme 4, eq. 5). 
Asymmetric synthesis of 1b still requires a method that involves the use of cheap 
and easily available chiral starting materials such as carbohydrates. Thus, 
following the lines drawn in the retrosynthetic Scheme 1, we use methyl-α-D-





















s,t,u,v 1b (eq. 4) [36]
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Scheme 4. Aymmetric total syntheses of 1b. Reagents and conditions: a) n-BuLi, 
CuI, THF, -30 oC; b) lithium acetylide ethylenediamine (4 eq), DMSO, rt; c) CO, 
PdCL2, CuCl2, AcONa, MeOH, rt; d) H2, Lindlar catalyst, quinoline, AcOEt, rt; e) 
conc. HCl-MeOH (1:3), rt; f) H2O2, cat. base; g) BF3.Et2O; h) NaOH; i) m-CPBA; j) 
LDA, Br2; k) Bu4NF; l) porcine pancreatic lipase (PPL), Et2O; m) POCl3, CH2Cl2, rt; 
n) baker’s yiest; o) triisopropylsilyl chloride, DMF, imidazole; p) ozone, CH2Cl2, -
70 oC and then dimethyl sulfide; q) BuLi, pentyl (triphenyl)-phosphonium 
bromide, THF, 20 oC; r) KOH, MeOH 16 h; s) sodium hydrogen carbonate, CH3CN, 
I2, 0oC, 3h; t) Bu3SnH, THF, reflux, 3h; u) aq HF, CH3CN, 7h; v) POCl3, pyridine, 
0oC→ 65oC, 5h; w) bis (tricyclohexylphosphine)-benzylidene ruthenium (IV) 
dichloride, CH2Cl2, reflux, 6h. 
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Benzylidene acetal 3 was regioselectively opened prior to the 2,3-dideoxygenation, 
under the conditions developed by Hanessian [18]. The 6-bromodiol 12, so 
prepared, was transformed to the 6-bromoolefine 13 by using 2,4,5-triimidazole, 
as described in ref. [15a] or by using iodoform/imidazole/triphenylphophine in 































Scheme 5. Asymmetric synthesis of R-(-)-massoilactone (1b) on carbohydrate 
scaffold. Reagents and conditions: a) NBS, CCl4, reflux; b)CHI3, imidazole, PPh3, 
toluene, reflux; c) n-BuLi, CuCN, THF, -30oC ; d) MsCl, pyridine, 5 oC; e) 
Superhydride , THF, reflux; f) MoO3, H2O2, and them Et3N and Ac2O. 
 
We envisioned at this point that nucleophilic attack by lithium dibutylcuprate 
would generate the intermediate 29. However, it was observed that nucleophilic 
displacement of bromine in 13 with lithium dibutyl cuprate, (n-Bu)2Cu(CN)Li2,  
obtained from n-butyl lithium and CuCN in the same flask [40], afforded 30 in 
good yield.  It seems that under highly basic conditions deprotection of the 
benzoyl group also take place. Mesylation of the resulting secondary alcohol was 
achieved almost quantitatively under standard methods. Hydride displacement of 
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the mesylate 31 with Superhydride was carried out successfully to yield 32. 
Anomeric oxidation with aqueous H2O2 in the presence of catalytic amounts of 
MoO3 [22] was conducted to produce R-(-)-massoilactone (1b) in 40% overall yield 
from 2. All the physical data (mass, NMR, optical rotation) corresponded to the 
natural massoilactone (1b). 
 
II.2. Osmundalactone (1c) 
 
(5S,6R)-Osmundalactone (1c) (pyran nomenclature is followed for numbering) was 
isolated by Buchanan from Paxillus atrotomentosus, a lignicolous mushroom [41]. 
Its absolute stereochemistry was determined as 5S,6R, when spectroscopic and 
optical rotation data were compared with the 5R,6S-enantiomer 34, which was 




34 R = H
34a R = Ac
O O
RO
1c R = H






Fig. 3. 5S,6R-Osmundalactone (1c), its enantiomer 34 
and their 5-O-acetylated derivatives 33 and 34a. 
 
Owing to some interesting biological activity [43], a number of syntheses on 34 
were reported [44-46]. However, to the best of our knowledge, only one synthesis 
for 1c has been achieved so far, based upon the resolution of the furyl methyl 
alcohol 35 [47] (Scheme 6). The enones 36 and 37 were further transformed to 
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the acetylated natural products 33 and 34a, respectively, in less than 20% overall 

























Scheme 6. Syntheses of both enantiomers of 5-O-acetylosmundalactone 33 and 
34a [47]. Reagents and conditions: a) Ti(OPri)4, D-(-)-DIPT, TBHP, CH2Cl2, b) NBS, 
THF:H2O (4:1) 
 
In order to extend our strategy for α,β−unsaturated δ−lactones from 
carbohydrates, we started to synthesize 1c. Methyl 6-bromo-4-benzoyl-2,3,4-
trideoxy-α-D-2-hex-enopyranoside (13), which failed to produce the triphenyl-
phonium salt 14 (see the total synthesis of S-argentilactone (11)), was chosen as 
a candidate for the formation of the allylic alcohol 38 by treating it with an excess 
of lithium triethylborohydride (Superhydride , 1 M in THF). The alcohol 38 was 
protected with acetic anhydride and finally oxidized at anomeric position to 
produce the target 5-O-acetylosmundalactone in excellent yield. The acetate 33 
can be exposed to enzymatic hydrolysis using the lipase „Amano P“ from 








38 R = H
39 R = Ac13
33 R = Ac
1c R = H
a c
b d  
 
 
Scheme 7. Asymmetric synthesis of acetylosmundalactone 32. Reagents and 
conditions: a) LiBHEt3, THF, rt and then heat at 40 oC for 30 min. b) Ac2O, Py, 5 








III. Total Synthesis  of R-(-)-Argentilactone (1a) 
 
Argentilactone (1a), an α,β-unsaturated δ-lactone, was originally isolated in 1977 
from the rhizomes of Aristolochia argentina Gris [6]. This compound is the major 
constituent of the essential oil and hexane extract of Annona haematantha [7] and 
also present in the methanolic extract of the leaves of Chorisia crispiflora [8]. The 
biological studies on 1a have  revealed high antileishmanial [7] and cytotoxic 
activity against P-388 mouse leukaemia cells [8]. Moreover, it can also be used as 
starting material for the synthesis of interesting pheromones [9]. These features 
prompted some research groups to undertake the total synthesis of this 
compound. 
In 1981, Fehr C. et al [10] reported the first synthesis of racemic argentilactone 
(1a), based on the dye-sensitised photooxigenation of dihydropyrane 41 and 
dehydration of the intermediate allylic hydroperoxide (Scheme 8, eq. 1). S. 
Chandrasekaran et al later on  improved the method by  using PDC/t-BuOOH as 
an oxiding reagent for dihydropyrans [13].  
B. O’Connor and G. Just [11], later on, reported on the total synthesis of 1a on 
carbohydrate scaffold (Scheme 8 eq. 2). Starting from the olefin 42, the aldehyde 
43 was obtained in about 49% yield over six steps. Finally, they obtained the 
target argentilactone over a series of reaction on 43 in around 10% overall yield 
from 42 [11]. L. Ghosez [12] employed an efficient strategy, by reacting the 
epoxide 44 with the anion generated from methyl 3-phenylsulphonylortho-
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propionate which subsequently underwent lactonization and elimination to 
































Scheme 8. Earlier syntheses of 1a. Reagents and conditions: a) Ph3P(CH2)5CH3Br, 
NaN(SiMe3)2, THF; b) 1O2, meso-tetraphenylporphine, toluene, irradiated with high 
pressure mercury lamp; c) Et3N, Ac2O, rt, overnight, d) n-BuLi, methyl 3-
phenylsulphonylorthopropionate; e) H3O+; f) p-TsOH; g) Et3N or DBU. 
 
In the first chapter of this thesis, the total synthesis of the non-natural 
enantiomer of argentilactone 11 from glucose has been described. As the 
stereochemistry of the natural argentilactone (1a) at C-6 (pyran nomenclature) is 
R, one needs a sugar from the L-series. If L-glucose would have been easily 
available, the strategy given in Scheme 3 would have been successful for the 
syntheses of R-(-)-argentilactone (1a) and other α,β−unsaturated δ-lactones 
having similar stereochemistry at C-6. In order to solve this stereochemical 
problem, we have applied the efficient method of F. M. Hauser [47] to convert 
commercially available D-glucal (46) into the optically active furan glycol 47, 
followed by inversion of the configuration at the asymmetric centre at C-2 by the 
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Mitsunobu reaction [48]. Although the authors used 2 equivalents of the reagent 
PPh3, DEAD and benzoic acid to produce the crystalline dibenzoate 48a in 92 % 
yield, we found that the use of one equivalent of reagent gave the monobenzoate 
48b with the free primary hydroxyl group in more than 80% yield containing 
dibenzoate 48a in less than 5% yield. Verification that the inversion was 
stereospecific was obtained from the fact that the optical rotation of 48c was 
identical in magnitude, but opposite in sign to that of the furandiol 47. 48c was 
prepared by hydrolysis of 48b and 48a. 
Thus, the commercially available D-glucal (46) was converted into the furandiol 
47 under the conditions (HgSO4, 0.002 M H2SO4) defined by Gonzalez and co-
workers [49] in 90% yield. The appearance of characteristic signals at δ 153.6, 
110.3 and 106.9 ppm in the 13C NMR spectrum of 47 indicated the furan moiety 
to be substituted at C-5. Inversion of the configuration of the secondary alcohol 
in 47 was carried out by the Mitsunobu reaction, using, 2.1 equivalents of PPh3, 
DEAD, and benzoic acid, each in dry THF, to produce the dibenzoate 48a (mp 82-
84 oC, [α]D25 –72.2, in CH2Cl2). The reaction was then repeated using the same 
conditions but a 1:1 equivalent amount of the reagents to yield the monobenzoate 
48b. A down-field absorption of the methane proton at δ 6.19 ppm of H-2 in the 
1H-NMR spectrum of 48b indicated the benzoylation of the secondary hydroxyl 
group. Furthermore, benzoylation (PhCOCl, Py, Et2O) of 48b yielded 48a with 
identical physical data, including the optical rotation. On the other hand, removal 
of the benzoyl group (MeOH/Et3N/H2O (5:1:4)) in 48b gave the furan glycol 48c, 
having the optical rotation, same in magnitude, but opposite in the sign ([α]D25 – 
36, in CH2Cl2) to 47, hence confirming the inversion of the configuration at C-2.  
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The free hydroxyl group was protected as tert-butyldiphenylsilyl ether (TBDPSCl, 
DMF, imidazole) [50] in quantitative yield to afford 49. Removal of the  benzoyl 
group was tested by reacting 49 with MeOH/H2O/Et3N, however the yield was 
low and most of the starting material was recovered back even after stirring at 
reflux for more than 36 h. Use of lithium aluminium hydride was also not 
successful because it removed the TBDPS group [51] to yield 48c. Finally, 
sodium in methanol was tried giving optimum result. Thus, catalytic sodium in 
methanol was used to afford the monohydroxyfuran derivative 50, protected at 















48a R, R1 = Bz
48b R = H, R1 = Bz
48c R, R1 = H
49 R = TBDPS, R1 = Bz







Scheme 9: Conversion of D-glucal (46) into furan-alcohol 50. Reagents and 
condititons: a) H2O/H+, HgSO4, rt, 3h, b) PPh3, DEAD, benzoic acid, THF, 2h, c) 
BzCl, Py, ether, d) MeOH, Et3N, H2O (5:1:4), overnight at rt, e) TBDPSCl, DMF, 
imidazole, 0 oC to rt, 2h, f) NaOCH3, MeOH. 
 
Having a successful preparation of the furan alcohol 50 from D-glucal (46) in 
hand, as next step the transformation of 50 into the L-hexenulose 51 was 
approached. This was accomplished smoothly when 50 was oxidized with NBS 
[54]. The hemiacetal 51, having the required stereochemistry at C-6 in the target 
argentilactone (1a), was obtained as a diastereometrically enriched (1:1) mixture 
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of anomers in deuterated chloroform. Because of its instability, 51 had to be 


























51 R = H
52 R = EE
c
b 53 R = H54 R = Msd 55
56 57 58
1a  
Scheme 10. Total synthesis of R-(-)-argentilactone 1a. Reagents and conditions: 
a) NBS, NaHCO3, NaOAC.3H2O, THF:H2O(4:1), 0 oC, 30 min., b) ethyl vinyl ether, 
PPTS, CH2Cl2, rt, 2h, c) CeCl3.7H2O, NaBH4, MeOH, -40 oC, 30 min., d) MsCl, Py, 
5 oC, e) LiBHEt3, THF, 40 oC, 3 h, f) tetrabutylammonium fluoride, THF, under 
nitrogen, 1 h, g) oxalyl chloride, DMSO, Et3N, CH2Cl2, -78 oC, 30 min., h) 
hexyltriphenylphosphonium bromide, n-BuLi, THF, -50 oC, i) H2O2, MoO3 
(catalytic), and then Et3N, Ac2O. 
 
The ketone 52 was reduced with NaBH4 in methanol at –40 oC in the presence of 
CeCl3.7H2O to give the trans product 53, which was mesylated (MsCl, Py, 5 oC) in 
excellent yield to produce the mesylate 54. The rest of the strategy was similar as 
was adopted for the synthesis of the non-natural enantiomer 11, i.e. the mesylate 
54 was treated with superhydride® to produce the C-5 deoxygenated product 55. 
The TBDPS group was removed with tetra-n-butylammonium fluoride in 
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quantitative yield and the generated primary alcohol 56 was subjected to Swern 
oxidation (oxalyl chloride, DMSO, Et3N, -78 oC) to produce the aldehyde 57 in 
90% yield. Wittig reaction of 57 with hexyltriphenylphosphonium bromide gave 
the olefin 58 in the desired cis configuration in 78% yield as was indicated by the 
coupling constant J7,8 = 10.2 Hz in the 1H NMR spectra of the final compound. 
Compound 58, an anomeric mixture, produced a very complex 1H NMR spectrum 
and the assignments were not carried out. Finally, 58 was oxidized by H2O2 in 
the presence of catalytic amounts of MoO3 to generate the target argentilactone 
(1a). All physical data (MS, 1H and 13C NMR, optical rotation etc) were found to be 
identical with those reported for the natural argentilactone [6]. Biological studies, 











Leishmaniasis, also known as „Kala Azar“, „black fever“ or „black sickness“ 
is caused by Protozoan parasites of the genus Leishmania. Although the 
infection is endemic in tropical and subtropical countries, it is spreading to 
Spain, southern France and Italy, reaching 88 countries world-wide. It has 
affected 12 million people and more than 350 million people are currently 
living in endangered areas [55]. According to the estimates of WHO, about 2 
million people are infected every year, and 500,000 suffer from visceral 
leishmania [56], a particular serious and, without treatment, always fatal 
form of the disease. 
Leishmania parasites exist in two forms: an amastigote in the mammalian 
host and a flagellated promastigote in the insect vector. The natural vectors 
of all leishmania are almost 30 species of sandflies (Phlebotominae). After a 
sandfly bites a Leishmania-infected mammal, amastigotes, present in the 
ingested blood, undergo a number of morphological changes in the insect’s 
abdominal midgut. This leads to the formation of haptomonad 
promastigotes, either free-swimming or attached to the cutile by flagella and 
free-swimming, highly motile, non-dividing metacyclic promastigotes, 
present mainly in the insect’s foregut [57]. This latter stage is transmitted 
into the skin of a mammalian host during the bite of an infected sandfly and 
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exhibits several preadaptations for this radical change of their environment 
[58]. In the mammalian skin, the metacyclic promastigotes bind to receptors 
on the surface of macrophages and are subsequently taken up by 
phagocytosis. Inside the host cell, the promastigotes rapidly transform 
within 12-24 h to amastigotes, while the initial phagosome matures to a 
phagolysosome by acidification and acquisition of lysosomal hydrolases.  
Within this hostile environment the amastigotes multiply, and eventually, 
the host cell lyses by an unknown mechanism. The released amastigotes 
spread by invasion and colonization of other macrophages. 
 
IV.2. Forms of leishmaniasis 
 
There are various forms of leishmaniasis. A particularly dangerous and often 
fatal form is visceral leishmaniasis (Kala Azar) which is caused by the 
pathogen Leishmania donovani. The parasites live in the liver, spleen and 
marrow and reproduce rapidly. Typical symptoms of visceral leishmaniasis 
are fever, tiredness and rheumatism along with general weakness which 
ends in a gradual but complete destruction of the liver and spleen. Without 
treatment, the infection results in death [59]. More recently, visceral 
Leishmaniasis has emerged as an opportunistic disease in AIDS patients 
[60). In addition to the visceral form, there are other forms of cutaneous 
leishmaniasis (oriental sores or oriental buttons) which cause skin ulcers 
and sometimes lead to a total disfigurement of the face. However these forms 
usually heal by themselves and are not lethal. 
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IV.3. Treatment 
IV.3.1. Physical methods 
 
Leishmania parasites are thermosensitive. In an in vitro study, L. tropica 
multiplied best at 35 oC and was completely eliminated at 37 oC [61]  In view 
of this feature, treatment of the local skin ulcers has been carried out by 
exposure to heat [62], irradiation with ultraviolet light and infrared therapy 
[63] , cryosurgery with a CO2 cryomachine [64]. Surgical excision such as 
scraping the lesions with a sharp spoon or cauterisation has also been 
employed. Currie treated 78 patients with cutaneous leishmaniasis in 
Pakistan by curettage under local anesthetics. He noticed that small sores 
responded especially well and heal within three weeks with good cosmetic 
results [65]. Treatment of lesions with skin flaps or free grafting in Saudi 
Arabia presented with good results [66], however, surgical curettage is not 
recommended in view of the risk of dissemination along lymphatics [67].  
 
IV.3.2. Drug therapy 
 
Since the earliest report of Kikuth and Schmidt [68], the pentavalent 
antimony compounds, sodium stibogluconate (Pentostam®, Wellcome 
Foundation, UK), and N-methylglucamine antimonate (Glucantime®, Specia, 
France) are still the drugs of choice for the treatment of visceral 
leishmaniasis [69,70]  and cutaneous leishmaniasis [71,72].  However, they 
are extremely toxic and show a number of side effects like cardiotoxicity, 
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reversible renal insufficience, pancreatitis, anemia, leukopenia, rash, 
headache, myagia etc [73]. In addition, treatment failure has been frequently 
observed [74-76]. More recently, strains of leishmania resistant to 
pentavalent antimonials have emerged and this has reached alarming 
proportions in  some contries [77]. Other drugs in use involve pentamidine 





In 1999, Barbara Herwaldt introduced Miltefosine as a new drug for the 
treatment of leishmaniasis, showing good results against leishmania 
donovani in the cell culture [81a]. In animal experiments, some problems 
were encountered in the initial trials by injecting miltefosine intravenously 
as this resulted in homolysis and significant changes in the tissue. Injecting 
it directly underneath the skin did not help as well because of extensive and 
intolerable ulcers and changes in the skin around the puncture point. 
Surprisingly, the oral intake of the substance via the alimentary canal 
worked well. The results were exciting and very revealing: the typical 
symptoms of the disease- enlargement of the liver and the spleen- did 
actually disappear rapidly. In comparison with the conventional pentostam 
therapy, the effect of miltefosine was at least 600 times better- a result 
which no one had ever dared to dream of after the negative experience with 






Fig. 4a. Structure of hexadecylphosphocholine (Miltefosine).  
 
Chemically, miltefosine is hexadecylphosphocholine, having a simple 
molecular structure (Fig. 4a). It was discovered by Hansjörg Eibl and 
Clemens Unger by studying the effect of structural modification in 
alkyllysolecithins on the antineoplastic activity of these compounds [81b]. 
Surprisingly, some of compounds like hexadecylphosphocholine were highly 
effective in animal models after oral applications and were, therefore, 
prepared for clinical studies. In many years of work, Eibel’s and Unger’s 
research groups developed the world-wide first drug that is based on the 
structure of the phospholipid molecule. They also tested miltefosine, as a 
drug useful against skin metastases in breast cancer, its effects against 




Twenty years after its isolation, argentilactone (1a) [6-8] was evaluated as an 
antileishmanial natural product [7]. The in vivo studies carried out on 
BALB/c mice, infected with Leishmania amazonensis, showed a decrease of 
the lesions size in treated mice, especially in the mice which have received 
argentilactone by the subcutaneous route; in this case, the decline of lesion 
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size was up to 50%. These results were comparable with those that were 
obtained with the reference drug, N-methylglucamine antimonate.  
These results prompted us to undertake the total synthesis of the natural 
compound. Chapter III of this thesis describes the synthetic pathway of 
argentilactone (1a). The impact of the synthetic argentilactone on the growth 
on Leishmania mexicana was then assessed. Leishmania (L) mexicana LV4 
(MNYC/BZ/62/M379, LEM280) promastigotes were grown in semi-defined 
medium 79 [82], supplemented with 4% heat-inactivated fatal calf serum at 
26-27 oC. To preserve their virulence, L. mexicana promastigotes were 
isolated from  mouse lesion amastigotes at 8-12 week intervals. For toxicity 
studies, cultures were seeded at 105/ml promastigotes with the addition of 
either 5 g/ml or 10 µg/ml argentilactone (dissolved in 5 mg/ml in 
dimethylsulphoxide) or equivalent volume solvent. After the initial lag phase 
(~90h), the promastigotes density was determined at 24 h intervals by 
triplicate counting of the cell numbers. 
In the present study the impact of the synthetic argentilactone on the growth 
of L. mexicana is assessed to investigate whether this substance is indeed 
the active principle of the above preparations. Fig. 4b shows the results of 
this assessment. At 5µg/ml concentration, synthetic argentilactone leads to 
marked growth retardation in promastigote cultures, while at 10µg/ml, the 
parasites are unable to proliferate and die within 2-3 days. These results 
unequivocally indicate the pharmacological activity of argentilactone. The 
efficiency of argentilactone against in vitro-cultured Leishmania proma-
stigotes is comparable to that of the main clinical anti-Leishmania drug, 
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sodium stiboglucanate [83]. This indicates the promising future for 
argentilactone to be used as a lead compound for the development of new 
anti-Leishmania drugs by a combination of chemical modifications of its 









V. 2,3-Anhydropentoses: Preparation of Starting Materials 
 
This part of the thesis demonstrates a veriety of examples for regio- and 
stereoselective transformations of 2,3-anhydropentoses delivering a series of 
chiral targets (Fig. 2) 
 
V.1.  Synthesis of benzyl 2,3-anhydro-β-L-ribopyranoside (64) [84a] 
The synthesis of the compound 64 was successfully performed in 6 steps, 
starting from the commercially available L-arabinose (59). Benzylation of L-
arabinose in the presence of hydrogen chloride leads to the anomerically 
protected benzyl β-L-arabinopyranoside (60) [85].  The cis-oriented hydroxyl 
groups at C-3 and C-4 were protected via 2,2-dimethoxypropane and p-toluene 
sulfonic acid (as a catalyst) in acetone, performing benzyl 3,4-di-O-
isopropylidene-β-L-arabinopyranoside (61). The free hydroxyl group at C-2 was 
directly tosylated with p-toluene sulfonyl chloride in pyridine, affording 
compound 62. The isopropylidene protecting group was selectively removed 
from 62 with 90% acetic acid to yield 63 [86]. The target compound 64 was 
finally obtained by the action of sodium methoxide in methanol on compound 
63, followed by the neutralization with dilute hydrochloric acid (Scheme11). 
 
V.2. Synthesis of benzyl 2,3-anhydro-α-D-ribopyranoside (73) [84a] 
The synthesis of compound 73 was achieved from D-arabinose (65), whereby it 
is known that direct benzylation does not yield the α-anomer in high quantity 
due the anomeric effect. In order to overcome this problem, one has to follow an 
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alternative procedure (Scheme 12) [87], in which 65 is converted to the 
tetrabenzoyl derivative 66 by the action of benzoyl chloride in pyridine. The 
anomeric mixture of compound 66 was treated with hydrogen bromide in 30% 
acetic acid to furnish 67 which, via an SN2 reaction with benzyl alcohol, affords 
the α-D-benzyl glycoside. The benzoyl groups in 68 were removed by sodium 































Scheme 11. Synthesis of benzyl 2,3-anhydro-β-L-ribopyranoside (64) from L-
arabinose (59) via benzyl β−L-arabinopyranoside (60), benzyl 3,4-O-
isopropylidene-β-L-arabinopyranoside (61), benzyl 3,4-O-isopropylidene-2-O-p-
tolylsulphonyl-β-L-arabinopyranoside (62) and benzyl 2-O-p-tolylsulphonyl-β-L-
arabinopyranoside (63). 
 
The target compound 73 was obtained following an analogous reaction 



























Scheme 12. Synthesis of benzyl α-D-arabinopyranoside (69) from D-arabinose 
(65) via the tetrabenzoate of arabinose (66), 2,3,4.tri-O-benzoyl-β-D-




























Scheme 13. Synthesis of benzyl 3,4-anhydro-α-D-ribopyranoside (73) via 
benzyl α-D-arabinopyranoside (69), benzyl 3,4-O-isopropylidene-α-D-arabino-
pyranoside (70), benzyl 3,4-O-isopropylidene-2-O-p-tolylsulphonyl-α-D-arabino-
pyranoside (71) and benzyl 2-O-p-tolylsulphonyl-α-D-arabinopyranoside (72). 
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V.3. Syntheses of benzyl 2,3-anhyro-4-O-triflyl-ribopyranosides [84a] 
The triflation of the free hydroxyl groups in 64 and 73 were successfully 
achieved at low temperature (-20 oC) via treatment with trifluoromethane-
sulfonic anhydride in dichloromethane. The triflates 74 and 75 were obtained 






















Scheme 14. Synthesis of benzyl 2,3-anhydro-4-O-triflyl-β-L-ribopyranoside (74) 
and benzyl 2,3-anhydro-4-O-triflyl-α-D-ribopyranoside (75) from benzyl 2,3-
anhydro-β-L-ribopyranoside (64) and benzyl 2,3-anhydro-α-D-ribopyranoside 
(73), respectively. 
 
V.4. Syntheses of benzyl 4-amino-2,3-anhydro-4-deoxy-lyxopyranosides [88] 
The reaction of epoxy triflates 74 and 75 with ammonia gas were carried out in 
acetone at –10 oC to afford benzyl 2,3-anhydro-4-amino-4-deoxy-α-D-
lyxopyranoside (76) and benzyl 2,3-anhydro-4-amino-4-deoxy-β-L-
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Scheme 15. Synthesis of benzyl 2,3-anhydro-4-amino-4-deoxy-α-D-







VI. Expeditious Syntheses of Optically Pure 1,4,5,6-Tetrahydro-
as-triazines, Fused to the Carbohydrate Skeleton 
 
 
Carbohydrates provide an important source for the synthesis of optically pure 
targets in organic and medicinal chemistry. The defined topology and 
stereochemistry of the carbohydrate framework permits an array of new 
strategies with unique synthetic properties to design artificial as well as natural 
materials [89,90]. Quite some time ago, we became interested in developing new 
methodologies for the synthesis of sugar-fused heterocycles [91]. Despite the 
achievements in the earlier described areas, we intended to expand the 
versatility and specificity of our strategies to other important targets. 
Substituted 1,4,5,6-tetrahydro-as-triazines like 78-81a-g (Fig 5) have been 
reported in literature [92-97)] showing insecticidal, herbicidal and fungicidal 
activities [92].  They can also prolong the hypnotic effects of barbiturates [93], 
act as analgesics [94,95], and also possess anticonvulsant properties [95]. 
However their syntheses suffer from the formation of a mixture of products 
[96,97] or involve hard reaction conditions [93,94]. Recently, one coworker of 
Voelter’s group has demonstrated that benzyl 4-amino-2,3-anhydro-4-deoxy-α-
D-lyxopyranoside (76) and benzyl 4-amino-2,3-anhydro-4-deoxy-β-L-
lyxopyranoside (77), containing an amino group adjacent to an oxirane ring, 
displayed electrophilic and nucleophilic reactivity which upon reaction with p-
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substituted phenylisothiocyanate afforded the corresponding thiazoline ring in 




























Fig. 5. Substituted 1,4,5,6-tetrahydro-as-triazines. 
 
In continuation of our interest in the synthesis of carbohydrate-fused 
heterocycles, we synthesized some representative examples of such as-
triazines, fused to the carbohydrate skeleton, which are, to the best of our 
knowledge, unknown so far.  
The potentials of the novel aminodeoxy sugars 76 and 77 were exploited further 
by reacting them with a 1,3-dipole such as nitrile imine 83, generated in situ 
from the reaction of triethyl amine onto the hydrazonoyl chlorides 82 [99]. The 
primary amine of 76 added readily on to the nitrile imine 83a-d to yield the 
intermediate (Z)-amidrazone adducts 84a-d [100] as the kinetically-controlled 
 a b c d e f g 
R o-Cl m-Cl p-Cl p-F p-NO2 m-Me p-MeO 
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product. The latter transient acyclic adduct underwent cyclization by opening 
the epoxide ring to yield pyrano[4,3-e][1,2,4]triazines 85a-d in good to excellent 
yields in a one step reaction. In the similar fashion, 77 reacted with 83a-d to 
produce the respective 1,2,4-triazines 87a-d via the intermediate amidrazones 
86a-d (Scheme 16). The general procedure involved adding hydrazonoyl 
chloride 82a-d (2 equiv.) to a stirred solution of 76 or 77 (200 mg) in methanol 
(10 ml) at 0 oC. Et3N (2 ml) was added dropwise within 10 min and the 
temperature was allowed to raise slowly to room temperature and further 
stirred for 4-6 h.  Normal work up and purification on silica gel column at 5% 
ethyl acetate in dichloromethane gave the desired triazines.  
1H  and 13C NMR, mass spectrometry and elemental analysis techniques were 
used to establish the structure of these compounds and unequivocally 
confirmed by X-Ray analysis. All compounds showed a prominent molecular ion 
peak in their FAB-MS spectra. The 13C NMR spectra showed a quaternary 
carbon resonance at about δ =150 ppm indicative of imine bond (C = N). C-3 
and C-4 appeared at δ = 54-56 and 46-48 ppm, respectively. Extensive 1H NMR 
studies enabled to diagnose the predominant conformation of the pyranose ring 




































































Scheme 16. Synthesis 1,4,5,6-tetrahydro-as-triazines on pyranose templates. 
Reagents and conditions: a) Et3N, MeOH, 0oC, b) 83a-d, MeOH; 0 oC and then at 
rt, 4-6 h. 
 
A salient feature of the 1H NMR spectra of the series 85a-d are the chemical 
shifts and the coupling constants of H-1 (δ = 4.33-4.42 ppm; J ∼ 7.9 Hz), 
indicating an axial-axial relationship between H-1 and H-2. The coupling 
interaction between H-2 and H-3 were found to be large in the range of 9-10 Hz, 
and thus showing that 1C4 is the predominant conformation in these 
compounds. For the other series 87a-d, small J1,2 coupling constants were 
 39
determined (3.36 Hz), indicating a quasi equatorial-axial relationship between 
the respective protons. In addition large J2,3 (around 10 Hz), confirmed 4C1 as 
the predominant conformation in this series. 
Figure 6 shows the ORTEP diagram of compound 85a with selected bond 
lengths and angles. C(4)-N(19) and C(3)-N(16) are found to have bond length 
values of 1.439(3) and 1.461(3) Å, respectively. A shorter bond length of the 
bond N(17)-C(18) is found with the value 1.303(3) Å indicating C=N bond. 
 
 
Fig. 6. The molecular structure of 85a. Selected bond lengths (Å) and bond 
angles (o): C(4)-N(19) 1.439(3); N (19)-C(18) 1.352(3); C(18)-N(17) 1.303(3); 
N(17)-N(16) 1.369 (3); N(16)-C(3) 1.461 (3); C(3)-C(4) 1.527 (3); C(5)-C(4)-N(19) 
111.1 (2); C(4)-N(19)-C(18) 120.2(2); N(19)-C(18)-N(17) 126.1 (2); C(18)-N(17)-







VII. A Convenient Method for the Synthesis of Cyclic 
Trithiocarbonates on Carbohydrate Scaffold 
 
The preparation of monosaccharides in which one or more oxygen atoms 
have been replaced by a sulfur atom has received considerable attention, 
primarily due to the fact that these compounds provide a route to the 
synthesis of deoxy sugars (101). Trithiocarbonate derivatives of 
carbohydrates are versatile intermediates for the synthesis of dithiosugars 
[102] and dideoxy sugars [103]. Many non-carbohydrate organic compounds 
containing trithiocarbonate moiety have been reported to possess interesting 
biological activities [104-107], but, to the best of our knowledge, no sugar-
embedded trithiocarbonate has been reported for its biological activity. 
Moreover only a few methods are available for the synthesis of such 
carbohydrate derivatives, such as the reaction of potassium methyl xanthate 
on epoxides [108] and episulphides [109] or in some cases the use of toxic 
thiophosgene gas [110]. 
The reaction of organic halides with sodium trithiocarbonate has been widely 
used for the preparation of disubstituted trithiocarbonates [111]. Moreover, 
alkyl mono- and dihalides, upon treatment with sodium trithiocarbonate, 
could easily be converted into the corresponding mono- or dimercaptan 
[112]. Recent efforts towards the preparation of dialkyl trithiocarbonates 
[113] prompted us to investigate the epoxy triflates 74 and 75 for possible 
candidates of sugar-based trithiocarbonates. 
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In the past, the triflates of the 2,3-anhydro-ribopyranosides 74 and 75 have 
been used by W. Voelter’s research group as starting materials towards the 
synthesis of either new useful chiral building blocks or biologically active 
natural products [114-116]. The strategy banks upon the difference in the 
reactivity between the cis-oriented triflate at C-4 as a powerful leaving group 
and the epoxide. This strategy enables us to control the regioselective 
nucleophilic displacement of the triflate group forming trans-oriented 
systems which can be further modified by chemical transformations. In this 
chapter, a simple and efficient route for the synthesis of cyclic 
trithiocarbonates 89 and 90 from the anhydrotriflates 74 and 75 is 
described (Scheme 17). The simple one pot reaction involves the addition of a 
red-colored  aqueous solution of Na2CS3  to a stirred solution  of benzyl 2,3-
anhydro-4-O-triflyl-β-L-ribopyranoside (74) (354 mg, 1 mmol) in ethanol (5 
ml) at room temperature over a period of 10 min. Na2CS3 can be produced by 
reacting Na2S (2,44 gm, 10 mmol) in water (5 ml) with CS2 (0.608 ml, 10 
mmol) with or without a phase transfer catalyst e.g. trioctylmethyl-
ammonium chloride (aliquat 336 ) (22.5 µl) [117]. The nucleophilic 
displacement of the triflyl group at C-4 by sulfur was followed by the 
simultaneous intramolecular ring opening of the epoxide to afford benzyl 
3,4-dideoxy-3,4-S-thiocabonyl-α-D-arabinopyranoside (89) in 95% yield. 
Similarly benzyl 2,3-anhydro-4-O-triflyl-α-L-ribopyranoside (75) yielded 
benzyl 3,4-dideoxy-3,4-S-thiocarbonyl-β-L-arabinopyranoside (90) in 90% 
yield. The reaction was then tested for triflates of other anhydrosugars. 
Benzyl 3,4-anhydro-2-O-triflyl-β-L-ribopyranoside (91) was prepared from 64 
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by a two step reaction [118]. After treatment with the solution of Na2CS3, 91 
is converted into trithiocarbonate 92 in a good yield (75%). However, the 
anhydrofuranoside 93 and 94 [119] gave a sluggish reaction to yield the 
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Scheme 17. Synthesis of sugar trithiocarbonates (89), 90, 92, 95 and 96 
from epoxytriflates 74, 75, 91, 93 and 94 respectively: Reagents and 




The structures of all products were established through MS, elemental 
analysis, 1H and 13C NMR spectroscopy. The conformations adopted by the 
pyranoside rings in the products 89 and 90 were determined by vicinal 
coupling constants and chemical shifts of their 1H NMR spectra. 5-H and 5′-
H were recognized easily from their large geminal coupling constant (∼ 13 Hz) 
at δ = 4.30 and 3.87 ppm, respectively in 89, and at δ = 4.15 and 3.88 ppm, 
respectively in 90. A symmetrical ddd pattern appeared for H-4 of 89 with 
J4,5 = 3.05, J4,5′ = 3.05 and J3,4 = 4.27 Hz. This indicates a quasi equatorial-
quasi equatorial relation between 4-H and 5’-H and a quasi equatorial-axial 
relationship between 4-H and 5-H; conformation of pyranoside ring in 89 is, 
therefore, predominately 1C4. This is further supported by large axial-axial 


































Fig. 7. Preferred conformations of the pyranose rings in 89 and 90 as 
determined from the coupling interactions in 1H NMR spectroscopy. 
 
On the other hand in 90 4-H appeared as a multiplet at δ = 4.81 ppm buried 
under the signal of the benzylidene protons. Although the direct calculation 
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of the coupling constant is not possible in this case, the coupling 
interactions of 4-H with 5-H and 5′-H were calculated from dd patterns 
observed for the latter protons, revealing a 1.83 Hz value for J4,5 and a 3.06 
Hz value for J4,5′. From these assignments we assumed a quasi equatorial 
position for 4-H; hence the pyranoside ring in 90 occurred predominately in 
the 4C1 conformation (Fig. 7). 
Fig 8 shows the ORTEP diagram of compound 90 with selected bond lengths 




















Fig 8. Molecular structure of 90. Selected bond length (Å) and angles (o): 
C(2)-O(8) 1.421 (3), C(3)-S(2) 1.817(3), S(2)-C(10) 1.734(3), C(10)-S(3) 
1.640(3), S(1)-C(10) 1.742(2), S(1)-C(4) 1.825(3); O(8)-C(2)-C(3) 111.3(2), C(2)-
C(3)-S(2) 110.3(2), S(2)-C(10)-S(1) 114.8(2), S(1)-C(10)-S(3) 122.9 (2), C(10)-
S(1)-C(4) 96.84 (12), S(1)-C(4)-C(5) 113.3(2). 
 
In summary, our new template 89, 90, 92, 95 and 96 would allow further 
elaboration to other targets through chemical modifications on the 





VIII. Synthesis and Properties of Selected 4-Substituted 
Anhydro Sugars 
 
Piperazine and its derivatives have earned a repute as medicinal and 
pharmaceutical interesting compounds, showing a broad spectrum of biological 
activities [120-123]. Some of 1,4-disubstituted piperazine derivatives show 
anticonvulsant [124], bronchospasmolytic [125], antipsychotic [126], and H1-
antagonist activity [127]. On the other hand, carbohydrate derivatives 
containing on oxirane rings are of current interest due to their enzyme 
inhibiting effect [128-131]. It is considered to be of high interest to extend the 
ongoing research and introduce some 4-substituted piperazines, morpholines 
and thiomorpholines into the 4-position of the cis-oriented epoxy triflates 74 
and 75 in order to obtain new compounds to be tested for the biological 
activities. 
Recently, Voelter’s group has reported a new methodology for the construction 
of the chiral piperazines on carbohydrate templates [132] and in continuation of 
this research, an easy access to 4-desoxy-4-[4-substituted-1-piperazinyl]-
pyranosides (97a-e and 98a-e; Scheme 18) is developed. 
Thus, the reaction of the epoxy triflate derivatives 74 and 75 with three 
equivalents of the 4-substituted piperazine derivatives in THF at room 
temperature affords after conventional work up the corresponding benzyl 4-(4-
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substituted-1-piperazinyl)-4-deoxy-2,3-anhydro-α-D-lyxopyranoside derivatives 
97a-e and their β-L-isomers 98a-e,respectively, Scheme 18. 
The facile nucleophlic substitution is due to the powerful triflyl leaving group 
and the strong nucleophilicity of the substituted piperazine derivatives. The 
reaction leads to the formation of lyxo products according to the inversion of 
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Scheme 18. Synthesis of 4-substituted piperazinyl-4-deoxy-2,3-anhydro-
pentopyranoside derivatives. Reagents and conditions: a) N N HR , THF, rt 
 
Vicinal coupling constants in the 1H NMR spectra are of great value in 
determining the predominant conformation of pyranoside rings, and in the 
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series 97a-e, J4,5 or J4,5’ is the important feature in determining their 
configuration. For compounds 98a-e, the protons at C-5 appear as broad 
triplets (accidentally J4,5 is equal to the geminal coupling constant J5,5’) with 
coupling constants in the range of 10-11 Hz, indicating a diaxial relationship 
for 4-H and 5-H and the conformation  is therefore predominantly oH5. In the 
other series, 98a-e, J4,5 or J4,5’ are small (0-4 Hz and 0 respectively), indicating 
axial-equatorial, equatorial-equatorial relationships and the adopted 
conformation is therefore again predominantly oH5. In a preliminary report from 
our group [133], the displacement of the triflate group with a variety of amino 
acids is described leading to products with conformations in full agreement 
with the structure presented here.  
All the newly synthesized compounds 97a-eand 98a-e, were tested in vitro, in 
the form of their hydrochloride salts in aqueous solutions, against E. coli 
ATCC11229, S. aureus ATCC6538 and C. albicans SATCC10231. The in vitro-
antibacterial activity was evaluated by the minimal inhibitory method [134]. For 
the positive control, the commercial antibiotic Ciprofloxacine was used. 
However, none of the above compounds showed any significant activity at 
concentration ≤ 500 µg/ml. 
In conclusion, introduction of the 2,3-anhydropyranoside at the position 4 of 
the piperazine moiety decrease the biological activity against selected types of 
bacteria and fungi, compared to piperazine derivatives containing alkyl or aryl 
substituents, therefore, it is worth to test these new compounds after 
hydrogenation of the benzyl group not only against bacteria or fungi, but also 
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their CNS depressant activity, since a large number of piperazine derivatives 
are CNS-depressant compounds. 
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C. Experimental Part 
All chemicals and reagents were obtained from commercial suppliers and 
used as such without further purification. Solvents were dried and distilled 
according to standard procedures. The reactions were monitored by thin 
layer chromatography, carried out on 0.25 mm silica gel plates (60 F-254, 
Merck, Darmstadt, Germany). Plates were visualized under UV light (where 
appropriate), sprayed with an orcinol/H2SO4/FeCl3 solution and heated to 
develop. Column chromatography was performed on silica gel 60 (0.063-
0.200 mm, Merck, Darmstadt, Germany) using the indicated solvent system. 
1H and 13C NMR spectra were obtained in CDCl3 on a Bruker AC 250 (1H 
NMR: 250 MHz, 13C NMR: 63 MHz) or a Bruker WM 400-spectrometer (1H 
NMR: 400 MHz, 13C NMR: 100 MHz ). The chemical shifts are reported in 
parts per million (ppm) on a δ scale from TMS as internal standard. The EI, 
FAB and FD mass spectra were recorded on a Finnigan MAT 312 mass 
spectrometer connected to a PDO 11/34 (DEC) computer system. Optical 
rotations were obtained with an LEP AZ polarimeter (Zeiss, Jena) at 546 nm. 
All melting points are uncorrected. 
 
C.1. Total synthesis of S-(+)-argentilactone (11) 
C.I.1. Methyl-4,6-O-benzylidene-α-D-glucopyranoside (3)  
To a stirred suspension of methyl α-D-glucopyranoside (2) (60 g, 0.31mol) in 
dry DMF (247 ml) was added α,α-dimethoxytoluene (47 ml, 0.31 mol) and p-
toluenesulfonic acid (6.18 g, 0.03 mol). The mixture was then refluxed on a 
steam bath under vacuum, produced by water aspirator, for 1 h. The solvent 
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was evaporated at reduced pressure and the solid material was suspended 
in hot aqueous NaHCO3. After cooling to room temperature, crystals of 
almost pure compound were obtained which were recrystallized in hot 
ethanol and dried in a desiccator under vacuum at 70 oC overnight to afford 
3 as colourless crystals. Yield 78.4 g (90%), m.p. 162-164 oC (ethanol); [α]D20 
+110 (c = 0.5, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 2.48 (s, 1 H, OH), 3.02 
(s, 1 H, OH), 3.44 (s, 3 H, OMe), 3.47 (dd, J = 9.3 and 9.1 Hz, 1 H, H-4), 3.61 
(dd, J = 3.9 and 9.5 Hz, 1 H, H-2), 3.72 (m, 2 H, 5-H, H-6’), 3.88 (dd, J = 9.5 
and 9.3 Hz, 1 H, H-3), 4.26 (dd, J =10.3 and 9.7 Hz, 1 H, H-6), 4.76 (d, J = 
3.9 Hz, 1 H, H-1), 5.5 (s, 1 H, PhCH), 7.33-7.87 (m, 5 H, PhH); 13C NMR (63 
MHz, CDCl3): δ = 55.4 (OMe), 62.3 (C-5), 68.8 (C-6), 71.6 (C-3), 72.8 (C-2), 
80.9 (C-4), 99.7 (C-1), 101.8 (PhCH), 126.2-129.7 (PhH). FAB-MS: m/z = 
283 (M+1, 100%). 
C14H18O6 (282.11) 
Calculated C 59.57 H 6.43%, 




To a stirred solution of benzylidene acetal 3 (30 g, 0.11 mol) in toluene (300 
ml) was added triphenylphosphine (115 g, 0.44 mol), iodoform (86.6 g, 0.22 
mol), and imidazole (15.0 g, 0.22 mol). With vigorous stirring the mixture 
was refluxed for 1 h. The solution was cooled and washed with saturated 
aqueous sodium bicarbonate. The organic layer was separated, dried over 
 51
MgSO4 and evaporated to dryness to yield a brown residue that was 
extracted with hot hexane. The solid material was filtered and the filtrate 
evaporated. Purification on a column of silica gel and eluting with dichloro-
methane/petroleum ether (80:20) gave 4 as a white solid. Yield 23.6 g (87%), 
m.p. 122 oC (ethanol); [α] D 25 +115.2 (c = 0.7, CH2Cl2); 1H NMR (250 MHz, 
CDCl3): δ = 3.46 (s, 3 H, OMe), 3.74-3.88 (m, 2 H, H-6 and H-6’), 4.12-4.17 
(m, 1 H, H-5), 4.31 (m, 1H, H-4), 4.90 (brs, 1 H, H-1), 5.58 (s, 1 H, PhCH), 
5.73 (dt, J = 10.37 and 2.45 Hz, 1 H, H-3), 6.14 (d, J = 10.37 Hz, 1 H, H-2), 
7.35-752 (m, 5H, PhH); 13C NMR (63 MHz, CDCl3): δ = 56.0, 64.0, 69.5, 75.3, 
96.2, 102.3, 126.3, 126.7, 128.4, 129.2, 130.9. FD-MS: m/z = 248.2 (M+, 
100%). 
C14H16O4 (248.10) 
Calculated C 67.73 H 6.50%, 
Found C 67.54 H 6.35%. 
 
C.I.3. Methyl 2,3-didehydro-2,3-dideoxy-α-D-erythro-hexoside (5) 
To a stirred solution of 4 (20 g, 0.08 mol) in absolute CH2Cl2 (100 ml) was 
added anhydrous tBuOOH (14.5 ml, 5.5 M sol. in decane) under nitrogen. 
After 10 min AlCl3 (10.7 g, 0.08 mol) was added and stirring was continued 
at the same temperature till TLC analysis showed no starting material. The 
reaction was quenched with slow addition of water and extracted with 
CH2Cl2 (2 x 100 ml). The combined organic layers were dried over anhydrous 





a colourless oil. Yield 10.3 g (75%); [α]D24 +104.3 (c = 1, methanol); 1H NMR 
(250 MHz, CDCl3): δ = 3.0 (br s, 1 H, OH), 3.44 (s, 3 H, OMe), 3.64-3.72 (m, 1 
H, H-5), 3.86 (br s, 2 H, H-6, H-6’), 4.18 (m, 1 H, H-4), 4.87 (br s, 1 H, H-1), 
5.74 (dt, J = 2.46 and 10.2 Hz, 1 H, H-3), 5.96 (d, J = 10.2 Hz, 1 H, H-2); 13C 
NMR (63 MHz, CDCl3): δ = 55.9 (OMe), 64.2 (C-6), 62.7, 71.5 (C-4, C-5), 95.4 
(C-1), 126.0, 133.7 (C-2, C-3). FAB-MS: m/z = 159.0 (M+-1). 
C7H12O4 (160.07) 
Calculated C 52.49 H 7.55%, 




To a stirred solution of 5 (10.3 g, 0.06 mol) in absolute pyridine (25 ml) was 
dropped a solution of benzoyl chloride (12.4 gm, 0.09 mol) in CH2Cl2 (15 ml) 
in such a rate that temperature did not rise above -5 oC. The reaction was 
stirred at the same temperature for 5 hr. The normal work up and 
purification of the crude material on a silica gel column with pure 
dichloromethane yielded 6 as a colourless oil. Yield 15.1 g (90%)   [α]D25 –12 
o (c = 0.5, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 3.39 (s, 3 H, OMe), 3.83-
3.88 (m, 1 H, H-5), 4.07 (d, J = 8.85 Hz, 1 H, H-4), 4.45 (dd, J = 2.14 and 
12.21 Hz,1 H, H-6’), 4.73 (dd, J = 4.88 and 12,21 Hz, 1 H, H-6), 4.85 (br s, 1 
H, H-1), 5.70 (dt, J = 2.44 and 10.37 Hz, 1 H, H-3), 5.92 (br d, J 10.37,1 H, 
H-2), 7.35-8.03 (m, 5 H, PhH); 13C NMR (63 ΜΗz, CDCl3): δ = 55.9, 64.0, 
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64.3, 70.6, 95.6, 126.4, 128.4, 129.8, 133.1, 133.3. FAB-MS: m/z = 233.1 
(M+-OMe).  
C14H16O6 (264.10) 
Calculated C 63.63 H 6.10%, 
Found C 62.99 H 6.03%. 
 
C.I.5. 2(S)-Methoxy-6(S)-hydroxymethyl-5,6-dihydro-2H-pyran (8) 
To a stirred solution of 6 (15 g, 0.057 mol) in pyridine (25 ml) at 0 oC was 
added mesyl chloride (5 ml). Stirring was continued at the same 
temperature for 4 hr. On completion of the reaction (TLC control), the 
mixture was plunged into a beaker containing crushed ice. The aqueous 
solution was extracted with ether (2 x 50 ml) and the combined organic 
layers were washed successively with a cooled 2 N HCl and saturated 
aqueous NaHCO3 solution, and finally with water. After drying over 
anhydrous Na2SO4, the solvent was removed at low pressure, the crude 
material was dissolved in dry THF and under nitrogen atmosphere and 
gentle stirring Superhydride® (5 ml, 1M solution in THF) was added at 0 oC. 
The temperature was slowly raised to 40 oC. After 3 h the TLC showed no 
starting material. Excess hydride was destroyed with slow addition of water, 
then a 3N NaOH solution (10 ml) was added, followed by the addition of a 
30% aqueous H2O2 solution (10 ml). The mixture was than brought into a 
separatory funnel and the THF layer was collected. The aqueous layer was 





anhydrous sodium sulfate and the solvent was removed. After flash 
chromatography on a silica gel column by eluting with 5% ethyl acetate in 
CH2Cl2 8 was obtained as colorless oil. Yield 5.76 g (70%) [α]D25 –75.3 o (c = 
0.74, C6H6); 1H NMR (250 MHz, CDCl3): δ = 1.99-1.81 (m, 1 H, H-4’), 2.25-
2.04 (m, 1 H, H-4), 2.29 (brs, 1 H, OH), 3.44 (s, 3 H, OMe), 3.82-3.54 (m, 2 
H, H-6’, H-5), 4.01 (m, 1 H, H-6), 4.90 (d, J = 2.0 Hz, 1 H, H-1), 5.81-5.70 
(m, 1 H, H-3), 6.09-5.98 (m, 1 H, H-2); 13C NMR (63 MHz, CDCl3): δ = 26.0, 
55.3, 65.2, 67.0, 95.7, 125.3, 128.6; EI-MS: m/z = 113 (M+-OMe). 
C7H12O3 (144.08) 
Calculated C58.32 H 8.39%, 
Found C 58.29 H 8.25%. 
 
C. I.6. 2(S)-Methoxy-5,6-dihydro-2H-pyran-6(S)-carbaldehyde (9) 
A solution of oxalyl chloride (4 ml) in of CH2Cl2 (75 ml) was brought in a 250 
ml three neck flask, equipped with two dropping funnels, containing DMSO 
(6.8 ml) in CH2Cl2 (20 ml) and alcohol 8 (5.76 gm, 40 mmol) in CH2Cl2 (40 
ml). At -78 oC DMSO was slowly dropped. The mixture was stirred for 2 min, 
then the alcohol was added within 5 min and stirring continued for 15 min. 
Triethylamine (30 ml) was added, the reaction mixture stirred for 5 min and 
then allowed to warm to room temperature. Water was added and the 
organic phase removed. The aqueous layer was further extracted with 
CH2Cl2 (50 ml), the organic layers were combined, dried and evaporated. The 
compound was finally purified by flash chromatography using pure CH2Cl2 
as an eluent to afford 9 as a colorless oil. Yield 5.11 g (90%); 1H NMR (250 
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MHz, CDCl3): δ = 2.10-2.22 (m, 2 H, H-4), 3.75 (s, 3 H, OMe), 4.40 (dd, J = 
4.8 and 10.1 Hz, 1 H, H-5), 5.19 (d, J = 2.6 Hz, 1 H, H-1), 5.79-5.68 (m, 1 H, 
H-3), 5.91-6.08 (m, 1 H, H-2), 9.71 (s, 1 H, H-6); 13C NMR (63 MHz, 
CDCl3): δ = 26.1, 62.3, 70.7, 92.8, 126.3, 126.4, 200.6. FAB-MS: m/z = 
141.1 (M+-1). 
C7H10O3 (142.06) 
Calculated C 59.14 H 7.09%, 
Found C 58.92 H 6.99%. 
 
C. I.7. 6(S)-Hept-1’-enyl-2(S)-methoxy-5,6-dihydro-2H-pyran (10) 
A solution of hexyltriphenylphsphonium bromide (15.34 g, 40 mmol) in a 
mixture of THF-HMPA (2:1, 150 ml) was cooled to -50 oC and n-BuLi (25 ml, 
1.6 M in hexane) was added via a syringe. After stirring for several min at 
the same temperature, a solution of aldehyde 9 (5.0 gm, 35.2 mmol) in  THF 
(25 ml) was added to the reaction mixture via a syringe. The solution was 
allowed to warm to -10 oC over 45 min, petroleum ether was added, followed 
by extraction with water, aqueous NaHCO3 and finally with water. The 
organic layer was separated, dried and evaporated under reduced pressure. 
The residue was chromatographed on a column of silica gel with CH2Cl2: 
hexane (80:20) as an eluent to afford pure 10 as colorless oil. Yield 6.09 g 
(80%); [α]D20 -50 o (c = 0.74, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 0.89 (t, J 
= 6.89 Hz, 3 H, CH3), 1.34 (m, 6 H, 3 x CH2), 2.01-2.30 (m, 4 H, 2 x CH2), 
3.38 (s, 3 H, OCH3), 3.75 (m, 1 H, H-6), 4.88 (br s, 1H, H-2), 5.48 (m, 1 H, 
H-10), 5.76 (m, 2 H, H-3, H-9), 6.08 (m, 1 H, H-4); 13C NMR (63 MHz, 
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CDCl3): δ = 14.0, 22.5, 23.1, 30.2, 32.0, 34.4, 55.5, 68.9, 96.2, 124.7, 
127.4, 130.7. FAB-MS: m/z = 210 (M+). 
C13H22O2 (210.16) 
Calculated C 74.24 H 10.54%, 
Found C 74.16 H 10.35%. 
 
C.I.8. (S)-(+)-argentilactone (11) 
To a suspension of 10 (6 gm, 22 mmol) in aqueous 30% H2O2 (250 ml) was 
added MoO3 (0.6 gm). The mixture was stirred at room temperature till 
completion of reaction (TLC control). After disappearance of the substrate, 
water (250 ml) was added and the mixture extracted with CH2Cl2 (4x 50 ml). 
The combined extracts were washed with water, dried, and concentrated to 
dryness, to afford an anomeric mixture of peroxide which was dissolved in 
CH2Cl2 (25 ml) and added dropwise to a cooled and stirred mixture (1:1) of 
acetic anhydride and pyridine (50 ml) at <30 oC. The mixture was stored at 
room temperature for 2 hr, then poured to crushed ice and extracted with 
CH2Cl2 (3x30 ml). The combined extracts were washed with saturated 
aqueous NaHCO3 and water, and dried and concentrated to dryness, to 
afford 11  as a yellow oil. Yield 2.99 g (70% over two steps); [α]D23 + 19.1 (c = 
0.5, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 0.88 (t, 3 H, Me), 1.3 (m, 6 H, 3 
x CH2), 2.10 (m, 2 H, CH2), 2.38 (m, 2 H, CH2), 5.0-5.8 (m, 3 H, H-5, H-6, H-
7), 6.04 (ddd, J = 10.3 and1.8 Hz, 1 H, H-2), 6.91 (ddd, J =10.3 and 4.2 Hz,1 
H, H-3); 13C NMR (63 MHz, CDCl3): δ = 14.0, 22.5, 27.8, 29.0, 29.9, 31.4, 
73.9, 121.7, 126.4, 135.7, 144.8. EI-MS: m/z =194 (M+). 
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C12H18O2 (194.13) 
Calculated C 74.19 H 9.34%, 
Found C 73.92 H 9.28%. 
 
C.II. Total Synthesis of massoilactone (1b) and osmundalactone(1c) 
C.II.1. Massoialactone (1b) 
C.II.1.1.  Methyl 4-O-benzoyl-6-bromo-6-deoxy-α-D-glucopyranoside (12) 
To a suspension of 3 (2.78 g, 10 mmol), 100 ml of carbon tetrachloride and 
7ml of 1,1,2,2-tetrachloroethane were added 1.95 g  of NBS and 1.2 g of 
barium carbonate. The suspension was heated at reflux with efficient stirring 
for 2.5 h and filtered while hot. The cake was washed with hot carbon 
tetrachloride and the filtrate and washing were evaporated to dryness. The 
resulting syrup was dissolved in ether (100 ml) and the solution was washed 
with water and dried (sodium sulfate). The evaporation of solvent afforded 
colorless syrup, which was purified by column chromatography using 
dichloromethane/ethyl acetate (50:50) as an eluting solvent. Yield 2.52 g 
(70%); white crystals, m.p. 124-125oC; [α]D25 = 116 o (c =1, CH2Cl2); 1H NMR 
(250 MHz, CDCl3): δ = 3.36 (m, 3 H, H-2, H-3, H-5), 3.46 (s, 3 H, OMe), 3.67 
(bs, 1 H, OH), 3.82 (bs, 1 H, OH), 3.94-4.11 (m, 2 H, H-6, H-6’), 4.79 (d, J = 
3.66 Hz, 1 H, H-1), 5.01 (t, J = 9.46 Hz, 1 H, H-4), 7.42 (t, J = 7.32 Hz, 2 H, 
Ph), 7.57 (t, J = 7.32 Hz, 1 H, Ph), 8.02 (d, J = 7.33 Hz, 2 H, Ph); 13C NMR 
(63 MHz, CDCl3): δ = 31.7 (C-6), 55.5 (OMe), 69.2, 72,2, 72.4, 73.5 (C-2, C-3, 
C-4, C-5), 99.0 (C-1), 128.4, 129.0, 129.8, 133.4 (C6H5), 165.9 (CO). FAB-
MS: m/z = 361.0 [M++1]. 
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C14H17BrO6 (360.02) 
Calculated C 46.56 H 4.74 Br 22.12%, 
Found C 46.30 H 4.65 Br 22.05%. 
 
C.II.1.2. Preparation of 2,4,5-triiodoimidazole 
Iodine (76.1 g, 0.3 mol) is stirred in hexane (1.5 l) at room temperature for 
0.5 h. Water (1.5 l) and imidazole (6.81 g, 0.1 mol) are added and then 
sodium hydroxide (32 g) in water ((400 ml), gradually in small portions 
whenever precipitation occurred (200-300 ml is generally required). After 
being stirred at room temperature for 24 h, the mixture is filtered. Most of 
the hexane layer is removed by decantation and discarded. The pH of the 
water layer is brought to about 5 by the gradual addition of conc. 
hydrochloric acid to the stirred solution. The precipitate is filtered off, 
washed thoroughly with water, and recrysrallized from ethanol/water to 
form large prisms. Yield 35.3 g (76%); m.p. 192-194oC. 
 
C. II.1.3. Methyl 4-O-benzoyl-6-bromo-2,3,4-trideoxy-α-D-erythro-hex-2-
enopyranoside (13) 
A mixture of methyl 4-O-benzyl-6-bromo-6-deoxy-α-D-glucopyranoside (12) 
(2.0 g, 5.6 mmol), triphenylphosphine (6.28 g, 24.0 mmol), 2,4,5-
triiodoimidazole (5.71 g, 12.8 mmol), and imidazole (1.09 g, 16.01 mmol) in 
dry toluene  (100 ml) was boiled under reflux for 2.5 h, after which time slow 
moving 12 was replaced with fast moving 13 (Rf ~0.8, PE/EtOAc (3:1)). After 
cooling the mixture to room temperature the solution was decanted from the 
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gummy residue into a conical flask containing a stirred saturated aqueous 
NaHCO3. The gummy residue was washed with several portions of ether and 
added to the sodium bicarbonate solution. The mixture was stirred for 15 
min and then transferred to a separatory funnel. The organic phase is 
washed once with saturated, aqueous sodium hydrogencarbonate, twice with 
saturated sodium thiosulfate and once with water. The organic layer 
separated, dried (MgSO4) and evaporated in vaccuo to give a brownish 
mixture of products from which some crystalline triphenylphosphonium 
oxide was separated by trituration with ether. The residual syrup was 
chromatographed on a column of silica gel by eluting with PE/EtOAc (20:80) 
to obtain pure 13 as colorless syrup. Yield 1.37 g (75%); 1H NMR (250 MHz, 
CDCl3): δ =3.18 (dd, J = 8.54 and 10. 7 Hz, 1 H, H-6’), 3.36-3.59 (m, 4 H, H-
6, OMe), 4.00 (dt, J = 2.44 and 8.85 Hz) , 4.21 (ddd, J = 2.44, 7.63 and 9.77 
Hz,  1 H, H-5), 4.94 (br s, 1H, H-1), 5.36, 5.46 (m, 1 H, H-4), 5.84 (m, 2 H, 
H-2, H-3), 7.39, 7.54 and 7.96 (3 x m, 5 H, C6H5); 13C NMR (63 MHz, CDCl3): 
δ = 5.5 (C-6), 32.4 (C-6), 56.4, 56.6 (OMe), 68.4, 68.8 (C-4), 70.0 (C-5), 95.8 
(C-1), 128.0 (C-2), 129.0 (C-3), 128.5-129.8, 133.6 (C6H5), 165.8 (CO). 
C14H15BrO4 (326.02) 
Calculated C 51.40 H 4.62 Br 24.42%, 




C.II.1.4. 2(S)-Methoxy-6(R)-pentyl-5,6-dihydro-2H-pyran (31) 
In a dry two-neck flask was placed CuCN (184 mg, 2.04 mmol). Under the 
supply of argon dry THF (2.2 ml) was introduced via a syringe and the slurry 
was cooled to –78 oC. To this slowly stirring suspension was added n-BuLi 
(3.9 mmol) dropwise. The heterogeneous mixture was allowed to warm 
gradually until complete dissolution (near 0 oC) and is then cooled again to –
78 oC. The bromo-sugar 13 (326 mg,1 mmol) was introduced at –78 oC, the 
solution was warmed to room temperature for 6 h and then quenched with a 
mixture of 10% conc. NH4OH/saturated aqueous NH4Cl solution and allowed 
to stir for 1 h. The extraction with ether (3 times), drying and evaporation of 
the solvent at low pressure yielded 28 as thick oil which was dissolved in 
pyridine (2 ml). At 0 oC was dropped a solution of mesyl chloride (120 µl) in 
CH2Cl2 (1 ml). In 5 h the mesylate 29 was received as yellow oil. Under a 
stream of nitrogen gas 29 was dissolved in freshly distilled THF and treated 
with lithium triethylborohydride (Superhydride®, 1 M solution in THF, 2 ml) 
via a syringe. The stirring at room temperature for 3 h showed the 
completion of reaction (TLC control). The standard work up and evaporation 
of the solvent yielded an oil. The purification on a short column of silica gel 
with dichloromethane as an eluent afforded 30 as a colorless oil. Yield 83 mg 
(45% form 13); 1H NMR (250 MHz, CDCl3): δ = 0.95 (t, 3 H, CH3), 1.1-2.2 (m, 
10 H, 4 x CH2, H-5, H-5’), 3.45 (s, 3 H, OMe), 3.95 (m, 1 H, H-6), 4.92 (br s, 
1 H, H-2), 6.2-5.6 (m, 2 H, C-3, C-4). FAB-MS: m/z = 185.1 [M++1] 
C11H20O2 (184.28) 
Calculated C 71.70 H 10.94%, 
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Found C71.56 H 10.58%. 
 
C.II.1.5. R (-)-Massoilactone (1b) 
 Pyran 31 (80 mg, 0.43 mmol), H2O2 (5 ml), MoO3 (12 mg) and a 1:1 mixture 
of acetic anhydride and pyridine was treated as was described for the 
synthesis of S (+)-argentilactone 11 (see page 48). Colorless liquid, Yield 42 
mg (56 %); [α]D20 = -102 o (c = 0.2, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 
0.89 ( br t, 3 H, CH3), 1.07-1.92 (m, 8 H, 4 x CH2), 2.16-2.45 (m, 2 H, H-5, 
H-5’), 4.12-4.53 (m, 1 H, H-6), 5.77-6.03 (m, 1 H, H-3), 6.67-6.92 (m, 1 H, H-
4); 13C NMR (63 MHz, CDCl3): δ = 14.0 (CH3), 22.4, 24.5, 29.4, 31.4, 34.9 (5 x 
CH2), 78.1(C-6), 121.5 (C-3), 145.0 (C-4), 165.1 (CO). FAB-MS; m/z = 169.1 
[M++1]. 
C10H16O2 (168.23) 
Calculated C 71.39 H 9.59%, 
Found C 71.35 H 9.45%. 
 
C.II.2. Osmundalctone (1c) 
C. II.2.1. Methyl 2,3,6-trideoxy-α-D-erythro-hex-2-enopyranoside (37) 
To a solution of bromo sugar 13 (326 mg, 1 mmol) in THF (10 ml, dried over 
Na) was added dropwise, at room temperature, 3 ml of an M solution of 
lithium triethylbirohydride (Superhydride® )in THF. The mixture was kept 
over night in a refrigerator, whereupon 13 was seen to be absent. The 
mixture was cooled to 0 oC, stirred for 30 min with added methanol, in order 
to decompose the excess of hydride. The solvent was evaporated and the 
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residue was placed on a short column of silica gel by mean of a little ethyl 
acetate. The elution with PE/EtOAc (3:1) gave pure 37 as colorless syrup. 
Yield 130 mg (90%); [α]D25 = +109 o(c = 1.2 , CH2Cl2); 1H NMR (250 MHz, 
CDCl3): δ = 1.29 (d, J = 6.02 Hz, 3 H, Me-6), 2.9 (brs, 1 H, OH), 3.42 (s, 3 H, 
OMe), 3.5-3.9 (m, 2 H, H-4, H-5),  4.80 ( brs, 1 H, H-1), 5.71 (dt, J= 10.3 Hz, 
1 H, H-2), 5.90 (dt, J = 10.02 Hz, 1 H, H-3); 13C NMR (63 MHz, CDCl3): δ = 
18.0 (Me-6), 55.5 (OMe), 68.0 (C-4), 69.5 (C-5), 95.4 (C-1), 126.2 (C-2), 133.4 
(C-3). EI-MS: m/z = 113 (M+-OMe). 
C7H12O3 (144.08) 
Calculated C 58.32 H 8.39%, 




To a stirred solution of the alcohol 37 (130 mg, 0.9 mmol) in 
dichloromethane (5 ml) containing triethylamine (1 ml) at 0 oC was added 
acetic anhydride (0.44 ml). On the completion of reaction, the solvent was 
evaporated and the residue was chromatographed on a short column of silica 
gel. The elution with ethyl acetate removed the triethylammonium salt and 
the effluent was evaporated to give the acetate 38 in a quantitative yield as a 





C.II.2.3. (+)-O-Acetylosmundalactone (32) 
The acetate 38 was oxidized at the anomeric position as described in the 
synthesis of S-(+)-argentilactone (11). Yield 110 mg (72%); [α]D25 = +158 oC ( 
c = 0.7, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 1.26 (d, J = 6.6 Hz, 3 H, C-
6), 1.97 (s, 3 H, CH3CO), 4.44 (m, 1 H, H-5), 5.12 (dd, J = 3.3 and 1.3 Hz, 1 
H, H-4), 5.93 (d, J = 10.1 Hz, 1 H, H-2), 6.66 (dd, J = 10.1 and 3.3 Hz, 1 H, 
H-3). EI-MS: m/z = 126 (M+-44). 
C8H10O4 (170.06) 
Calculated C 56.47 H 5.92%, 
Found C 56.50 H 6.01%. 
 
C.III. Total Synthesis of R-(-)-argentilactone (1a) 
C. III.1. 1R-(2’-Furyl)-ethane-1,2-diol (47) 
A solution of D-glucal (46) (5.0 g, 0.034 mol) in 5mM sulfuric acid (118 ml) 
containing mercuric sulfate (0.197 g) was stirred for 2 h at room 
temperature. TLC examination, then, showed the completion of reaction. The 
acid was neutralized with barium carbonate, the suspension was filtered and 
the filtrate was evaporated in vacuo to afford a light yellow residue. The 
purification on a column of silica gel after eluting with ether/petrol ether 
(7:3) yielded 47 as a thick oil. Yield 3.7 (85%); [α]D25 = + 38.0 (c = 0.3, 
CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 3.59 (br s, 1 H, OH), 3.80 (d, J = 
5.49 Hz, 2 H, H-2), 3.99 (br s, 1 H, OH), 4.75 (t, J = 5.49 Hz, 1 H, H-1), 6.27-




(63 MHz, CDCl3): δ = 65.0 (C-2), 68.4 (C-1), 106.9, 110.3 (C-3’, C-4’), 153.6 
(C-5’), 153.6 (C-2’). EI-MS: m/z = 128 [M+] 
C6H8O3 (128.13) 
Calculated C 56.24 H 6.29%, 
Found C 55.84 H 5.99%. 
 
C.III.2. Benzoic acid 1S-(2’-furyl)-2-hydroxyethyl ester (48 b) 
In a two-neck flask, furandiol 47 (1.28 g, 10 mmol) was dissolved in 100 ml 
of freshly distilled and dried THF. Triphenylphophine (3.94 g, 15 mmol), and 
benzoic acid (1.22 g, 10 mmol) were added into it. A dropping funnel, 
containing a solution of diethyl azodicarboxylate (DEAD, 2.36 ml), in 25 ml 
of THF was attached in one neck and a condenser in the second one. The 
solution of the funnel was let to drop slowly into the stirred contents of the 
flask over a period of 2 h. The stirring was continued a further period of 1 h 
after the final drop and TLC showed the completion of the reaction. The 
solvent was evaporated and the residual oil was triturated to crystallize 
triphenylphosphine. The filtration removed the crystals and evaporation of 
the filtrate left a thick oil which was placed on a column of silica gel with the 
help of a little dichloromethane. The elution with 15% ethyl acetate in 
petroleum ether removed most of the low polar impurities. The polarity was 
increase slowly to 20% ethyl acetate/pet. ether to afford 48b as a colorless 
oil. Yield 1.86 g (80%); [α]D20 = -17.6 o (c = 1.4, CH2Cl2); 1H NMR (250 MHz, 
CDCl3): δ = 4.09 (dd, J = 4.88 and 12.21 Hz, 1 H, H-2), 4.18 (dd, J = 7.02 
and 12.21 Hz, 1 H, H-2), 6.19 (dd, J = 4.88 and 7.02 Hz, 1 H, H-1), 6.37 (dd,  
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J = 1.83 and 3.35 Hz, 1 H, H-2’), 6.49 (d, J = 3.36 Hz, 1 H, H-4’), 7.43 (m, 3 
H, H-5’, 2 x H-2’’), 7.56 (tt, J = 1.53 and 7.05 Hz, 1 H, H-3’’), 8.06 (dd, J = 
1.23 and 8.24 Hz, 2 H, H-1’’); 13C NMR (63 MHz, CDCl3): δ = 63.23 (C-2), 
70.21 (C-1), 109 (C-3’), 110.5 (C-4’), 128.46, 129.88, 133.3 (aromatic). 
C13H12O4 (232.23) 
Calculated C 67.23 H 5.21%, 
Found C 67.30 H 4.96%. 
 
C. III.3. Benzoic acid 2-benzoyloxy-1S-(2’-furyl)-ethyl ester (48a) 
The above experiment was carried out with furandiol 47 (256 mg, 2mmol), 
DEAD (0.63 ml), PPh3 (1.048 g) and benzoic acsid (0.5 g) in 25 ml THF to get 
the dibenzoate 48a as a solid. The removal of triphenylphosphine oxide was 
accomplished by flash column chromatography by using 5% ethyl 
acetate/petroleum ether as an eluent. Yield 403 mg (60%), m.p. = 71-73 oC; 
[α]D20 = -18.7 o (c = 0.2, CH2Cl2). Alternatively, to a stirred solution of 48b 
(232 mg, 1 mmol) in pyridine (5 ml) at 0oC, benzoyl chloride (1 ml) in CH2Cl2 
(2 ml) was dropped slowly. The reaction was monitored by TLC. After 
completion of the reaction the aqueous work up was performed to yield 48a.  
C20H16O5 (336.34) 
Calculated C 71.42 H 4.79%, 







C.III.4. Benzoic acid 1S-(2’-furyl)-2-tert-butyldiphenylsilyloxyethyl ester 
(49) 
To a stirred solution of furan-monalcohol 47b (1.5 g, 6.5 mmol) in dry DMF 
(10 ml), containing 2.2 equiv. of imidazole (0.97 g) was added slowly tert-
butyldiphenylsilyl chloride (1.96 g, 7.15 mmol) at 0 oC. The ice bath is 
removed and the temperature is allowed to rise slowly to room temperature. 
Stirring the reaction mixture for a period of 4 h at room temperature showed 
the completion of reaction (TLC analysis). The solvent was removed at high 
vacuum, the residual oil was dissolved in 10 ml dichloromethane and 
extracted with water (5 ml, 3 times). The organic layer was separated, dried 
(Na2SO4), and evaporated in vacuo to yield sufficiently pure 49 as an oil in 
almost quantitative yield. The reaction was also carried out in pyridine to 
afford an excellent yield of 49. Thus 47b (143 mg, 0.62 mmol) was dissolved 
in 2 ml pyridine and under continued stirring was added TBDPSCl (1.1 
equiv.) at 0 oC. The ice bath was removed and the reaction was stirred at rt 
for 2 h, after which the reaction was almost completed. 1H NMR (250 MHz, 
CDCl3): δ = 1.0 (s, 9 H, 3 x CH3), 4.09 (dd, J = 5.18 and 10.98 Hz, 1 H, H-2´), 
4.19 (dd, J = 7.32 and 10.68 Hz, 1 H, H-2), 6.30 (dd, J = 5.5 and 7.63 Hz, 1 
H, H-1), 6.33 ( dd, J = 1.83 and 3.05 Hz, 1 H, H-4’), 6.44 (br d, J = 3.35 Hz, 1 
H, H-3’), 7.24-7.71 (m, 14 H, H-5’, aromatic protons), 8.05 (dd, J = 8.05 and 
1.2 Hz, 2 H, Ph); 13C NMR (63 MHz, CDCl3): δ = 19.2 (C-Me3), 26.7 (3 x CH3), 
64.0 ( C-2), 69.8 (C-1), 109.4, 110.4 (C-3’, C-4’), 127.7, 128.3, 129.8, 129.9, 
133.1, 133.2, 135.7 (aromatic). FAB-MS: m/z = 413.1 [M- C4H9]+ 
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C29H30O4Si (470.63) 
Calculated C 74.01 H 6.43 Si 5.97%, 
Found C 73.78 H 6.29 Si 5.95%. 
 
C. III.5. 2-tert-Butyldiphenylsilyloxy-1S-(2’-furyl)-1S-ethanol (50) 
To a stirred solution of 49 (3.0 g, 6.4 mmol) in 25 ml of absolute methanol at 
0 oC was added dropwise a freshly prepared solution of sodium methoxide 
(prepared by dissolving 30 mg sodium in 15 ml methanol). The stirring was 
continued till the completion of reaction (TLC control), after which the 
solution was neutralized with 1 N HCl. The solution is filtered (if there is 
precipitation due to the salt formation) and the filtrate is evaporated to 
dryness. The oily residue is purified on a column of silica gel by eluting with 
CH2Cl2/petroleum ether (1:1) to afford 50 as colorless oil. Yield 2.0 g (85%) 
[α]D20 = - 8.36 (c = 0.7, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 1.06 (br s, 9 
H, 3 x CH3), 3.92 (m, 2 H, H-2, H-2), 4.82 (br t, J = 5.15 Hz, 1 H, H-1), 6.27-
6.32 (m, 2 H, H-3’, H-4’), 7.33-7.43 (m, 6 H, H-5’, Ph), 7.59-7.72 (m, 5 H, 
Ph); 13C NMR (63 MHz, CDCl3): δ = 19.3 (C-Me3), 26.9 (3 x CH3), 66.4 ( C-2), 
68.5 (C-1), 107.2, 110.3 (C-3’, C-4’), 127.8, 127.9, 129.7, 129.9, 132.9, 
134.9, 135.6 (aromatic), 153.6 (H-2’). FAB-MS: m/z = 413.1 [M- C4H9]+ 
C22H26O3Si (366.53) 
Calculated C 72.09 H 7.15 Si 7.66%, 








Compound 50 (1.5 g, 4.1 mmol), 7 ml of THF and 1.75 ml of water were 
added to a round bottom flask and cooled to 0 oC. NaHCO3 (0.68 g), 
NaOAc.3H20 (556 mg) and NBS (0.73 g, 4.1 mmol) were added to the 
solution and the mixture was stirred for 1 hour at 0 oC. The reaction was 
quenched with saturated NaHCO3 (10 ml), extracted with ether (3 x 15 ml), 
dried (Na2SO4) and concentrated under reduced pressure to give 1.33 g 
(85%) of 51 as a colorless solid, m.p. 124-127 oC; Yield 1.4 g (91%); 1H NMR 
of the anomeric mixture (250 MHz, CDCl3): δ = 1.0 (s, 9H, 3 x CH3), 4.05 (m, 
2 H, -CH2-OTBDPS), 4.33 (dd, J = 3.05 and 2.14 Hz, H-2β), 5.59 (dd, J = 
4.27 and 2.44 Hz, H-2α), 5.53 (br s, H-6α), 5.76 (d, J = 3.05 Hz, H-6β), 6.16 
(d, J = 10.38 Hz, H-4β), 6.26 (d, J = 10.38 Hz, H-4 α), 6.92 (dd, J = 10.38 and 
3.05 Hz, H-5β), 7.02 (d, J = 10.38 Hz, H-5α), 7.40 and 7.66 (m, 10 H, Ph); 
13C NMR (63 MHz, CDCl3): δ = 19.3 (C-Me3), 26.6 and 26.8 (3 x CH3), 66.05, 
64.04 (CH2),  79.6 (C-2), 88.0, 87.4 (C-6), 127.7-147.1 (Ph), 135.5, 135.7, 
135.9 (C-4, C-5),194.7, 194.4 (CO).  
C22H26O4Si (382.52) 
Calculated C 69.08 H 6.85 Si 7.34%, 







To a solution of enone 51 (1.3 g, 3.4 mmol) in dichloromethane (20 ml) was 
added ethyl vinyl ether (2.44 g, 3.24 ml) and pyridinium p-toluenesulfonate 
(PPTS, 60 mg). The mixture was stirred for 1.5 h, and then H2O (5 ml) was 
added, extracted by dichloromethane (15 ml x 3) and dried over Na2SO4. 
After the removal of the solvent the residue was purified through column 
chromatography using 5% ethyl acetate/petroleum ether, as an eluent, to 
afford 52 as an oil. Yield 1.47 (95 %); [α]D20 = +10.21 0 (c = 0.5, CH2Cl2); 1H 
NMR (250 MHz, CDCl3): δ =  1.01, 1.02 (2 x s, 9 H, 3 x CH3), 1.19, 1.24 (2 x 
t, J = 7.02 Hz, 3 H, CH3), 1.40, 1.44 (2 x d, J = 5.19 Hz, 3 H, CH3), 3.74-3.40 
(m, 2H), 4.02-3.98 (m, 2H), 4.53, 4.60 (2 x dd, J = 2.74 and 5.18 Hz, 1 H), 
4.97, 5.08 (2 x q, J = 5.19 Hz, 1 H), 5.58 (d, J = 3.36 Hz), 6.07 (d, J = 10.07 
Hz, H-3), 6.85-6.75 (m, 1 H, H-2), 7.38-7.27 8m, 6 H, PhH), 7.63 (m, 4 H, 
PhH); 13C NMR (63 MHz, CDCl3): δ = 15.2, 15.4, 19.3, 20.9, 21.1, 26.7, 61.8, 
63.3, 63.6, 88.0, 88.2, 89.8, 98.7, 100.0, 127.7-135.7, 144.02, 144.7, 194.5, 
194.7. 
C26H34O5Si (454.63) 
Calculated C 68.69 H 7.54 Si 6.18%, 







C. III.8. 6-(1’-Ethoxyethyl)-3 R -hydroxy-2 S -tert-butyldiphenylsilyloxy-
methyl-3,6-dihydro-2H-pyran (53) 
At –40 oC, NaBH4 (0.58 g) was added portionwise to a solution of 52 (1.4 g, 
3.08 mmol) in methanol (20 ml) containing CeCl3.7H2O (1.15 g, 3.08 mmol). 
The reaction was monitored by TLC. The reaction was quenched with water 
(15 ml) and extracted with ether (30 ml x 3), the ether layer was washed with 
brine and dried over Na2SO4. The allylic alcohol 53 was obtained 
quantitatively as colorless oil. Yield 1.22 g (87%); 1H NMR (250 MHz, CDCl3): 
δ =  1.06 (s, 9 H, 3 x CH3), 1.09-1.21 (m, 3 H, CH3), 1.26-1.35 (m, 3 H, CH3), 
3.32-3.92 (m, 6H), 4.82, 4.92 (2 x m, 1H), 5.15, 5.24 (2 x m, 1 H), 5.66-5.79 
(m, 1 H), 5.97 (brd, J = 10.38 Hz, 1 H, H-2), 7.35-7.46, 7.66-7.72 (2 x m, 10 
H, PhH); 13C NMR (63 MHz, CDCl3): δ = 15.1, 15.4(CH3), 19.2 (C), 21.0, 21.3 
(CH3), 26.9 (3 x CH3), 61.6, 62.8, 65.7, 65.9, 66.4, 66.5, 70.7, 70.9 (C-4, C-5, 
C-6, CH2) 89.7, 91.0, 98.1, 99.4, 125.9-135.6. 
C26H36O5Si (456.65) 
Calculated C 68.39 H 7.95 Si 6.15%, 




To a stirred solution of the allylic alcohol 53 (1.20 g, 2.63 mmol) in pyridine 
(10 ml) was dropped slowly mesyl chloride at 0 oC. The stirring was 
continued at the same temperature till the completion of reaction (TLC 
control). After completion, the contents of the reaction flask were poured on 
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ice, extracted with dichloromethane, dried (Na2SO4) and evaporated to afford 
54 as colorless oil which was dissolved in THF (5 ml). Under nitrogen 
atmosphere was added lithium triethylborohydride (Superhydride , 1 M 
solution in THF, 1 ml). The reaction was monitored by TLC. After completion, 
methanol was added to destroy the excess hydride. The solvent was 
evaporated and the residue was placed on a column of silica gel with the 
help of little dichloromethane. Elution with 80% dichloromethane/petroleum 
ether yielded 55 as a colorless oil. Yield 1.1 g (95%).  
C26H36O4Si (440.65) 
Calculated C 70.87 H 8.23 Si 6.37%, 
Found C 70.73 H 8.16 Si 6.35%. 
 
C. III.10. 6-(1’-Ethoxyethyl)-2S-hydroxymethyl-3,6-dihydro-2H-pyran 
(56) 
To a stirred solution of 55 (1.1 g, 2.5 mmol) in THF was added tetra-n-
butylammonium fluoride (1 M solution in THF, 5 ml). Stirring was continued 
at room temperature for a period of 3h, which showed completion of the 
reaction. Water (10 ml) was added, extracted with dichloromethane (10 ml, 3 
times), dried (Na2SO4) and evaporated to yield 56 as colorless oil. Yield 500 
mg (99%). 
C10H18O4 (202.25) 
Calculated C 59.39 H 8.97%, 





C.III.11. 6-(1’-Ethoxyethyl)-3,6-dihydro-2H-pyran-2R -carbaldehyde (57) 
The alcohol 56 (500 mg, 2.47 mmol)), oxalyl chloride (247 µl), DMSO (420 µl) 
and triethylamine (1.85 ml) were treated as described for the synthesis of 9 
(see page 51). Yield 419 mg (85%). 
C19H16O4 (200.23) 
Calculated C 59.98 H 8.05%, 
Found C 59.67 H 7.98%. 
 
C. III.12. 2R-Hept-1-enyl-6-(1’-ethoxyethyl)-3,6-dihydro-2H-pyran (58) 
The aldehyde 57 (400 mg, 2 mmol), n-hexyltriphenylphosphonium bromide 
(871 mg), n-BuLi (1.42 ml) were treated as described for the synthesis of 
10(see page 52). Yield 375 mg 870%).  
C16H28O3 (268.39) 
Calculated C 71.60 H 10.52%, 
Found C 71.45 H 10.49%. 
 
C. III.13. R-(-)-argentilactone (1a) 
Pyran 56 (80 mg, 0.43 mmol), H2O2 (5 ml), MoO3 (12 mg) and a 1:1 mixture 
of acetic anhydride and pyridine was treated as was described for the 
synthesis of R (+)-argentilactone 11 (see page 48). Yellow oil, yield 2.99 g 
(70% over two steps); [α]D23 - 19.9 (c = 0.5, CH2Cl2); 1H NMR (250 MHz, 
CDCl3): δ = 0.88 (t, 3 H, Me), 1.3 (m, 6 H, 3 x CH2), 2.10 (m, 2 H, CH2), 2.38 
(m, 2 H, CH2), 5.0-5.8 (m, 3 H, H-5, H-6, H-7), 6.04 (ddd, J = 10.3 and1.8 
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Hz, 1 H, H-2), 6.91 (ddd, J =10.3 and 4.2 Hz,1 H, H-3); 13C NMR (63 MHz, 
CDCl3): δ = 14.0, 22.5, 27.8, 29.0, 29.9, 31.4, 73.9, 121.7, 126.4, 135.7, 
144.8. EI-MS: m/z =194 (M+). 
C12H18O2 (194.13) 
Calculated 74.19% H 9.34%, 
Found C 73.92 H 9.28%. 
 
C.V. Syntheses of starting 2,3-anhydro-pentopyranosides 
C. V. 1. Benzyl 2,3-anhydro-β-L-ribopyranoside (62) 
C. V.1.1. Benzyl β-L-arabinopyranoside (58) 
58 was prepared from 50 gm (0.33 mol) L. arabinose (57) and 250 ml freshly 
distilled benzyl alcohol and 1000 ml abs. Ether as described in reference 
[84b]. Yield: 73 g (91%); m.p. 171-173 oC (ethanol/H2O), ref [84b]: 168-171 
oC (ethanol); [α]D = +210o (c = 1, H2O), ref. [84b]: +206 o (c = 0.3, H2O). 
C12H16O5 (240.23) 
Calculated C 59.99 H 6.70%, 
Found C 59.55  H 6.50%. 
 
C.V.1.2. Benzyl 3,4-O-isopropylidene-β-L-arabinopyranoside (59) 
59 was prepared from 72 gm of 2 (0.3 mol), 500 ml 2,2-dimethoxypropane 
and 1 g p-toluensulphonic acid in 500 ml acetone. The resultant syrup 59 






C. V.1.3 Benzyl 3,4-O-isopropylidene-2-O-p-tolylsulphonyl-β-L-arabino-
pyranoside (60) 
60 was prepared from 75 g (0.27 mol) of 59, dissolved in 500 ml pyridine 
and 199 g p-toluensulphonyl chloride as described in ref. [84a]: Yield: 107.3 
g (92%); m.p. 93-95 oC (ethanol/H2O), ref [84a]: 93-94 oC (ethanol/H2O); [α]D 
= +183o (c = 1, CHCl3), ref. [84a]: +183 o (c =  1, CHCl3). 
C22H26O7S (434.47) 
Calculated C 60.81 H 6.02 S 7.37%, 
Found C 60.61  H 6.06 S 7.15%. 
 
C. V.1.4. Benzyl 2-O-p-tolylsulphonyl-β-L-arabinopyranoside (61) 
61 was prepared from 107 g (0.24 mol) of 60 and 100 ml 90% acetic acid as 
described in ref. [84a]. Yield: 88.7 g (91%); m.p. 119-120 oC (methanol/H2O), 
ref [84a]: 118-120 oC (methanol/H2O); [α]D = +128o (c = 1, CHCl3), ref. [84a]: 
+134 o (c =  1, CHCl3). 
C19H22O7S (394.41) 
Calculated C 51.81 H 4.61 S 8.12%, 
Found C 57.71  H 5.50 S 8.05%. 
 
C. V.1. Benzyl 2,3-anhydro-β-L-ribopyranoside (62) 
62 was prepared from 88 g (0.224 mol) of 61, 950 ml methanol and 7.1 g 
(0.3 mol) sodium. Yield: 28.7 g (92.6%); m.p. 76-77 oC (EE), ref [84a]: 76-77 
oC (EE); [α]D = - 13 o (c = 1, EE), ref. [84a]: -11 o (c =  1, EE). 
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C12H14O4 (222.22) 
Calculated C 64.86 H 6.34% 
Found C 64.32  H 6.32%. 
 
C.V.2.  Benzyl 2,3-anhydro-α-D-ribopyranoside (71) 
C.V.2.1. Tetrabenzoate of β-D-arabinopyranoside (64) 
64 was prepared from 50 g (0.33 mol) D-arabinose 63, 300 ml CH2Cl2, 100 
ml pyridine and 250 ml benzoyl chloride as described in ref. [55a]. Yield: 170 
g (90%); m.p. 172-173 oC (ethanol), ref. [84a] 175 oC (ethanol); [α]D = -321 o 
(c = 1, CHCl3), ref. [84a]: -322 o (c = 1, ethanol). 
C33H26O9 (566.56) 
Calculated C 69.96 H 4.63%, 
Found C 70.35 H 4.52%. 
 
C.V.2.2. 2,3,4-Tri-O-benzoyl-β-D-arabinopyranosyl bromide (65) 
65 was prepared from 170 g 64, 200 ml CH2Cl2 and 320 ml HBr/acetic acid 
(33%) as described in the ref. [84a]. Yield: 125 g (79%); m.p. 144-146 oC 
(CH2Cl2/EE), ref. [84a]: 146-148 oC (EE); [α]D = -358 o (c = 1, CHCl3), ref. 
[87a]: -353.3 (c = 1.4, CHCl3). 
C26H21BrO9 (524.05) 
Calculated C 59.44 H 4.03 Br 15.21%, 




C.V.2.3. Benzyl 2,3,4-tri-O-benzoyl-α-D-arabinopyranoside (66) 
66 was prepared from 125 g 65, 1000 ml benzyl alcohol, as described in ref. 
[84a]. Yield 112 g (85%); m.p. 143-144 oC (ethanol), ref. [87a]: 143-144 oC 
(ethanol); [α]D = -153 o (c = 1, CHCl3), ref. [87a]: -146.7 [c = 2.11, CHCl3). 
C32H28O8 (552.55) 
Calculated C 71.73 H 5.11%, 
Found C 72.26 H 5.07%. 
 
C.V.2.4. Benzyl α-D-arabinopyranoside (67) 
67 was prepared from 112 g 66, 365 ml CH2Cl2 and 250 ml MeOH and 2.5 g 
sodium as described in ref. [84a]. Yield: 47 g (96%); m.p. 138.139 oC 
(ethanol), ref. [87a]: 140-141 oC (ethanol); [α]D = +12 o (c = 1, H2O), ref. [87a]: 
+12.3 o (c = 1, H2O). 
C12H16O5 (240.23) 
Calculated C 59.99 H 6.71%, 
Found C 59.80 H 6.50%. 
 
C.V.2.5. Benzyl 3,4-O-isopropylidene-α-D-arabinopyranoside (68) 
68 was prepared from 47 g 67, 500 ml acetone, 300 ml 2,2-
dimethoxypropane and 1 g p-toluenesulfonic acid as described in ref. [84a]. 
the product was not characterized, and was used as such for the next step. 






69 was prepared from 48.9 g 68, 600 ml pyridine and 199 g p-
toluenesulfonyl chloride as describe in ref. [84a]. Yield: 62.5 g (82.5%); m.p. 
82-83 oC (ethanol/H2O),ref. [84a]: 80-82 oC (ethanol/H2O); [α]D = -10 o (c = 1, 
CHCl3), ref. [84a]: -7 o( c = 1, CHCl3). 
C22H26O7S (434.47) 
Calculated C 60.81 H 6.02 S 7.37%, 
Found C 61.02 H 6.00 S 7.20%. 
 
C.V.2.7. Benzyl 2-O-tolylsulphonyl-α-D-arabinopyranoside (70) 
70 was prepared from 62.5 g 69, 100 ml 90% acetic acid as described in ref. 
[84a]. Yield: 51.4 (90%); m.p. 110-112 oC (ethanol/H2O) ref. [84a]: 116-117 
oC (methanol/H2O); [α]D = +22 o(c = 1, CHCl3), ref. [84a]: + 25 o (c = 1, CHCl3). 
C19H22O7S (394.41) 
Calculated C 57.81 H 5.61 S 8.12%, 
Found C 57.64 H 5.60 S 8.02%. 
 
C.V.2. Benzyl 2,3-anhydro-α-D-ribopyranoside (71) 
71 was prepared from 51.9 g 70, 950 ml methanol and 3.6 g sodium as 
describe in ref. [84a]. Yield: 20.88 g (72%); m.p. 96-97 oC (EE/PE), ref. [84a]: 
97-98 oC (PE); [α]D = +190 o(c = 1, EE), ref. [84a]: +188 o(c = 1, EE) 
C12H14O4 (222.22) 
Calculated C 64.86 H 6.34%, 
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Found C 64.56 H 6.22%.  
 
C.V.3. Benzyl 2,3-anhydro-4-O-triflyl-β-L-ribopyranoside (72) and -α-D-
ribopyranoside (73) 
72 and 73 were prepared from 2.22 g (10 mmol) 62 and 71 respectively, 75 
ml CH2Cl2, 2 ml pyridine and 1.8 ml (10.97 mmol) trifluoromethanesulfonic 
anhydride (Tf2O), synthesized as described in ref. [84a]. 
 
C.V.3.1. Benzyl 2,3-anhydro-4-O-triflyl-β-L-ribopyranoside (72) 
Yield: 3.13 g (90%); m.p. 83-84 oC (ethanol), ref. [84a]: 82-83 oC (ethanol); 
[α]D = +16 o (c = 1, CHCl3),ref. [84a]: +16 o(c =1, CHCl3) 
C13H13F3O6S (354.29) 
Calculated  C 44.07 H 3.69 S 9.04%, 
Found C 43.85 H 3.60 S 9.25%. 
 
C.V.3.2. Benzyl 2,3-anhydro-4-O-triflyl-α-D-ribopyranoside (73) 
Yield: 3.3 g (94.3%); m.p. 67-68 oC (ethanol), ref. [84a]: 66-68 oC (ethanol); 
[α]D = +126 o (c = 1, CHCl3),ref. [84a]: +128 o(c =1, CHCl3) 
C13H13F3O6S (354.29) 
Calculated  C 44.07 H 3.69 S 9.04%, 




C.V.4 Standard procedure for the syntheses of the amino sugars 74 and 
75 
The amino deoxy sugar 74 and 75 were prepared following the published 
procedure [88] by passing ammonia gas through a solution of epoxy triflates 
72 and 73 in acetone at -10 oC for 1 h, followed by the aqueous work up in 
the conventional manner. 
 
C.V.4.1 Benzyl 4-Amino-4-deoxy-2,3-anhydro-α-D-lyxopyranoside (74) 
Yield: 73%; m.p. 46-48 oC; [α]D20 = +93 o (c = 0.20, CH2Cl2). 
C12H15NO3 (221.11) 
Calculated C 65.14 H 6.83 N 6.33%, 
Found C 64.99 H 6.81 N 6.30%. 
 
C.V.4.2. Benzyl 4-Amino-4-deoxy-2,3-anhydro-β-L-lyxopyranoside (75) 
Yield: 73%; m.p. 35-37 oC; [α]D20 = +102 o (c = 0.25, CH2Cl2). 
C12H15NO3 (221.11) 
Calculated C 65.14 H 6.83 N 6.33%, 
Found C 64.99 H 6.81 N 6.30%. 
 
C.VI. Synthesis of chiral as-triazines 
C.VI.1. General procedure for the preparation of hydrazonoyl chloride 
(i) The particular arylamine (0.1 mol) was dissolved in cold aqueous 
hydrochloric acid (80 ml, 5N). To this solution was added dropwise a solution 
of sodium nitrite (7.6 g, 0.11 mol) in water (25 ml) with efficient stirring at 0- 
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5 oC. Stirring was continued for 20-30 min and the resulting fresh cold 
arenediazonium chloride solution was used immediately as such for the 
following coupling step. 
(ii) A cold (-5 oC), freshly prepared solution of the particular arenediazonium 
chloride (0.1 mol) was poured onto a cooled solution (-8 oC, ice-salt bath) of 
α-chloroacetylacetone (13.5 g, 0.1 mol) in pyridine/water (140 ml, 1:1 v/v) 
with vigorous stirring. Stirring of the resulting yellow mixture was continued 
until a cold precipitate was formed (5-10 min). The reaction mixture was 
then diluted with cold water, dried, and recrystallized from the appropriate 
solvent. 
 
C.VI.2. General procedure for the preparation of as-triazines 
To a solution of the appropriate hydrazonoyl chloride (1 mmol) in a mixture 
of dichloromethane and methanol (10 ml, 1:1) was added a solution of the 
aminosugar 75 or 76 (1 mmol) in methanol (2 ml). Triethylamine (1 ml) in 
methanol was then dropwise added to the stirred mixture at 0 oC. Stirring 
was continued at 0 oC for 2-4 h, and then at ambient temperature for 5-12 h 
till TLC showed no starting aminosugar.  The solvent was then removed in 
vacuo and the residue was washed with water. The resulting crude solid was 








Yellow crystals; yield 324 mg (85%); [α]D25 = +606.4 o(c = 0.04, CH2Cl2); 1H 
NMR (250 MHz, CDCl3): δ = 2.5 (s, 3 H, CH3), 3.43 (br s, 1H, H-4), 3.55 (dd, J 
= 7.9 and 9.7 Hz, 1 H, H-2 ), 3.76 (dd, J = 1.5 and 13.13 hz, 1 H, H-5’), 4.07 
(dd, J = 1.5 and 13.13 Hz, 1 H, H-5), 3.84 (dd, J = 3.35 and 9.7 Hz, 1 H, H-
3), 4.42 (d, J = 7.77 Hz, 1 H, H-I), 4.59 (d, J = 11.5 Hz, 1 H, PhCHH), 4.88 (d, 
J = 11.5 Hz, 1 H, PhCHH), 5.54 (s, 1 H, NH), 6.90 (m, 1 H, PhH), 7.26-7.32 
(m, 7 H, PhH), 7.40-7.44 (m, 2 H, PhH); 13C NMR (63 MHz, CDCl3): δ = 23.5 
(CH3), 46.9, 54.7 (C-3, C-4), 65.5 (C-5), 68.5 (C-2), 71.1 (PhCH2), 103.4 (C-
1), 114.9, 120.5, 128.1, 128.3, 128.6, 128.9 (Ph) FAB-MS: m/z = 381.1 (M+). 
C21H23N3O4 (381.43) 
Calculated C 66.13 H 6.03 N 11.02%, 




Yellow crystals; yield 350 mg (85%); [α]D25 = +690.6 o (c = 0.13, CH2Cl2); 1H 
NMR (250 MHz, CDCl3): δ = 2.5 (s, 3 H, CH3), 3.77 (m, 3 H, H-2, H-3, H-5’), 
4.08 (d, J = 12.8 Hz, 1 H, H-5), 4.41 (d, J = 7.97 Hz, 1 H, H-I), 4.62 (d, J = 
11.6 Hz, 1 H, PhCHH), 4.90 (d, J = 11.6 Hz, 1 H, PhCHH), 5.29 (s, 3H, OMe), 
6.86 (m, 2 H, PhH), 7.33 (m, 7 H, PhH); FAB-MS: m/z = 411.3 (M+). 
C22H25N3O5 (411.45) 
Calculated C 64.22 H 6.12 N 10.21%, 
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Yellow crystals, m.p. 111-113 oC; yield 312 mg (78%); [α]D25 = +617.0 o(c = 
0.1, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 2.5 (s, 3 H, CH3), 3.42 (m, 1 H, 
H-4), 3.52 (dd, J = 7.63 and 9.76 Hz, 1 H, H-2), 3.75 (dd, J =1.53 and 13.4 
Hz, 1 H, H-5’), 4.06 (dd, J = 1.53 and 13.12 Hz, 1 H, H-5), 4.22 (dd, J = 3.36 
and 9.76 Hz, 1 H, H-3), 4.40 (d, J = 7.63 Hz, 1 H, H-1), 4.57 (d, J = 11.6 Hz, 
1 H, PhCHH), 4.87 (d, J = 11.6 Hz, 1 H, PhCHH), 5.55 (s, 1H, OMe), 6.98 (m, 
2 H, PhH), 7.29 (m, 5 H, PhH), 7.25-7.37 (m, 2 H, PhH); 13C NMR (63 MHz, 
CDCl3): δ = 23.5 (CH3), 46.9, 55.3 (C-3, C-4), 65.4 (C-5), 68.5 (C-2), 71.1 
(PhCH2), 103.4 (C-1), 115.1, 115.4, 116.3, 116.4, 128.2, 128.3, 128.6 (Ph) 
FAB-MS: m/z = 399.1 (M+). 
C21H22FN3O4 (399.42) 
Calculated C 63.15 H 5.55 N 10.52 F 4.76%, 




Yellow oil; yield 300 mg (72%); [α]D25 = +457.4 o(c = 0.1, CH2Cl2); 1H NMR 
(250 MHz, CDCl3): δ = 2.5 (s, 3 H, CH3), 3.54 (m, 3 H, H-2, H-3, H-4), 3.69 (d, 





and 9.76 Hz, 1 H), 4.37 (d, J = 7.94 Hz, 1 H, H-1), 4.50 (d, J = 11.3 Hz, 1 H, 
PhCHH), 4.81 (d, J = 11.3 Hz, 1 H, PhCHH), 5.73 (s, 1H, NH), 6.83-6.86 (m,  
2 H, PhH), 7.13-7.42 (m, 5 H, PhH), 7.42-7.43 (m, 2 H, PhH); 13C NMR (63 
MHz, CDCl3): δ = 23.6 (CH3), 47.0, 54.4 (C-3, C-4), 65.1 (C-5), 68.2 (C-2), 
71.3 (PhCH2), 103.6 (C-1), 112.8, 114.8, 119.9, 128.2, 128.3, 128.5, 129.7, 
134.7, 140.3, 147.8 (Ph), 193.3 (CO). FAB-MS: m/z = 415.0 (M+). 
C21H22ClN3O4 (415.87) 
Calculated C 60.65 H 5.33 N 10.10 Cl 8.52%, 




Yellow crystals; yield 300 mg (79%); [α]D25 = -476.6 o(c = 0.05, CH2Cl2); 1H 
NMR (400 MHz, CDCl3): δ = 2.50 (s, 3 H, CH3), 3.52 (br s, 1H, H-3), 3.68 (dd, 
J = 0.8 and 12.00 Hz, 1 H, H-5’), 3.70 (m, 1 H, H-4),4.11 (dd, J = 0.8 and 
12.00 Hz, 1 H, H-5), 4.60 (d, J = 11.9 Hz, 1 H, PhCHH), 4.64 (m, 1 H, H-4), 
4.81 (d, J = 11.9 Hz, 1 H, PhCHH), 4.97 (d, J = 3.36 Hz, 1 H, H-1), 5.43 (s, 1 
H, NH), 6.82-7.42 (m, 10 H, PhH); 13C NMR (100 MHz, CDCl3): δ = 23.3 
(CH3), 46.9 (C-3), 52.0 (C-4), 61.5 (C-5), 66.3 (C-2), 69.8 (PhCH2), 98.3 (C-1), 
114.4, 120.5, 128.1, 128.3, 128.6, 128.9, 146.8 (Ph), 1982.3 (CO). FAB-MS: 
m/z = 381.1 (M+). 
C21H23N3O4 (381.43) 
Calculated C 66.13 H 6.03 N 11.02%, 






Yellow solid, m.p. 170 oC (decomp.); yield 350 mg (85%); [α]D25 = -442.5 o (c = 
0.1, CH2Cl2); 1H NMR (250 MHz, CDCl3): δ = 2.5 (s, 3 H, CH3), 3.70 (dd, J = 
1.5 and 12.80 Hz, 1 H, H-5’), 3.77 (s, 3 H, OMe), 3.80 (m, 1 H, H-2), 4.11 
(dd, J = 1.5 and 12.8 Hz, 1 H, H-5), 4.52 (m, 1 H, H-4), 4.59 (d, J = 11.8 Hz, 
1 H, PhCHH), 4.81 (d, J = 11.8 Hz, 1 H, PhCHH), 4.98 (d, J = 3.6 Hz, 1 H, H-
1),5.38 (s, 1H, NH), 6.83-6.92 and 7.16-7.40 (m, 9 H, PhH); 13C NMR (63 
MHz, CDCl3): δ = 23.3 (CH3), 46.8, 53,4 (C-3, C-4), 61.6 (C-5), 66.5 (C-2), 
69.9 (CH2Ph), 98.5 (C-1), 114.4, 116.4, 128.2, 128.7 (Ph), 193.0 (CO). FAB-
MS: m/z = 411.3 (M+). 
C22H25N3O5 (411.45) 
Calculated C 64.22 H 6.12 N 10.21%, 




Yellow oil; yield 312 mg (78%); [α]D25 = -295.2 o(c = 0.16, CH2Cl2); 1H NMR 
(250 MHz, CDCl3): δ = 2.50 (s, 3 H, CH3), 3.54 (brs, 1 H, H-3), 3.68-3.79 (m, 
2 H, H-2, H-5’), 4.12 (dd, J = 1.8 and 12.81 Hz, 1 H, H-5), 4.54 (m, 1 H, H-4), 
4.60 (d, J = 11.6 Hz, 1 H, PhCHH), 4.82 (d, J = 11.6 Hz, 1 H, PhCHH), 4.98 
(d, J = 3.6 Hz, 1 H, H-1), 5.45 (s, 1 H, NH),  6.95-7.01, 7.16-7.41 (m, 9 H, 





Calculated C 63.15 H 5.55 N 10.52 F 4.76%, 




Yellow oil; yield 300 mg (72%); [α]D25 = -303.2 o(c = 0.16, CH2Cl2); 1H NMR 
(250 MHz, CDCl3): δ = 2.52 (s, 3 H, CH3), 3.55 (brs, 1 H, H-3), 3.71 (m, 2 H, 
H-2, H-5’), 4.12 (dd, J = 1.5 and 12.8 Hz, 1 H, H-5), 4.59 (m, 2 H, H-4, 
PhCHH), 4.83 (d, J = 11.7 Hz, 1 H, PhCHH), 4.98 (d, J = 3.6 Hz, 1 H, H-1), 
5.52 (s, 1H, NH), 6.82-6.87 (m, 2 H, PhH), 7.14-7.42 (m, 5 H, PhH), 7.42-
7.43 (m, 2 H, PhH); 13C NMR (63 MHz, CDCl3): δ = 23.5 (CH3), 47.2, 52.0 (C-
3, C-4), 61.4 (C-5), 66.3 (C-2), 70.0 (PhCH2), 98.3 (C-1), 112.3, 114.6, 120.2, 
128.2, 128.3, 128.5, 129.7, 134.7, 140.3, 147.8 (Ph), 193.3 (CO). FAB-MS: 
m/z = 415.0 (M+). 
C21H22ClN3O4 (415.87) 
Calculated C 60.65 H 5.33 N 10.10 Cl 8.52%, 
Found C 60.56 H 5.31 N 10.06 Cl 8.45%. 
 
C.VII. General procedure for the preparation of trithiocarbonates 
Sodium sulfide (479 mg, 2 mmol) was dissolved in 100 ml water at 30 oC. To 
this solution was added 189 mg (2.5 mmol) carbon disulfide. The reaction 
mixture was warmed to 40 oC and allowed to stir for 6 h. The excess carbon 
disulfide was removed by evaporation at reduced pressure. To the  
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resulting deep red-colored solution was dropped slowly a solution of 354 mg 
(1 mmol) triflate 75 and 76, respectively in little amount of ethanol. Stirring 
at room temperature for 10 min produced the trithiocarbonates as yellow 
colored precipitates.  
 
 
C.VII.1. Benzyl 3,4-dideoxy-3,4-S-thiocabonyl-α-D-arabinopyranoside 
(89) 
Yellow crystals, m.p. 131-133 oC, 1H NMR (250 MHz, CDCl3): δ = 3.87 (dd, J 
= 3.35 and 13.42 Hz, 1H, H-5’), 4.07 (m, 2H, H-3, H-2), 4.30 (dd, J = 3.05 
and 13.42 Hz, 1H, H-5), 4.46 (d, J = 6.41 Hz, 1H, H-1), 4.62 (d, J = 11.9 Hz, 
1 H, PhCHH), 4.76 (ddd, J = 4.27 and 3.05 Hz, 1 H, H-4), 4.95 (d, J = 11.9 
Hz, 1 H, PhCHH), 7.36-7.38 (m, 5 H, PhH); 13C NMR (63MHz, CDCl3): δ = 
58.7, 61.4 (C-3, C-4), 61.6 (C-5), 69.9 (C-2), 70.8 (CHHPh), 102.3 (C-1), 
128.1, 128.3, 128.7 (Ph), 162.1 (C=S). FAB-MS: m/z = 384.1 (M+) 
C13H14O3S3 (314.45) 
Calculated C 49.66 H 4.49 S 30.59%, 
Found C 49.58 H 4.45 S 30.56%. 
 
C.VII.2. Benzyl 3,4-dideoxy-3,4-S-thiocabonyl-β-L-arabinopyranoside 
(90) 
Yellow crystals, m.p. 162.3 oC, 1H NMR (250 MHz, CDCl3): δ = 3.88 (dd, J = 
1.83 and 13.42 Hz, 1H, H-5’), 4.17 (m, 3H, H-5, H-3, H-2), 4.61 (d, J = 11.6 
Hz, 1 H, PhCHH), 4.81 (m, 2 H, H-4, PhCHH), 5.07 (brs, 1H, H-1), 7.34-7.42 
(m, 5 H, PhH); 13C NMR (63 MHz, CDCl3):δ = 56.8 (C-5), 60.09, 60.38 (C-3,  
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C-4), 68.3 (C-2), 70.4 (CHHPh), 97.05 (C-1), 128.3, 128.5, 128.8 (Ph). FAB-
MS: m/z = 384.1 (M+) 
C13H14O3S3 (314.45) 
Calculated C 49.66 H 4.49 S 30.59%, 
Found C 49.58 H 4.45 S 30.56%. 
 
C.VII.3. Methyl 3,5-dideoxy-3,5-S-thiocarbonyl-α-D-xylofuranoside (94) 
Yellow oil; 1H NMR (250 MHz, CDCl3): δ = 3.35 (s, 3H, OCH3), 3.52 (m, 2H), 
3.66 (m, 2 H), 4.29 (t, J = 7.3 Hz, 1 H, H-4), 5.23 (s, 1 H, H-1); 13C NMR (63 
MHz, CDCl3):δ = 38.6 (C-5), 55.7 (C-3), 56.1 (OCH3), 75.7 (C-2), 102.7 (C-1). 
FAB-MS: m/z = 207.1 (M+-OCH3) 
C7H10O3S3 (238.35) 
Calculated C 35.27 H 4.23 S 40.36%, 
Found C 35.15 H 4.16 S 40.34%. 
 
C.VIII. General procedure for the preparation of compounds 97a-e and 
98a-e 
To a stirred solution of the epoxy triflate 62 or 71 (354 mg, 1 mmol) in 10 ml 
dry THF, 3 mmol of the corresponding substituted piperazine was added. 
The reaction mixture was then stirred until TLC analysis showed no more 
starting material. The aqueous work up yielded the 4-substituted 








Yellow oil; Yield 0.258 g (85%); [α]D20 = +77.3 o (c = 0.35, CH2Cl2): 1H NMR 
(250 MHz, CDCl3): δ = 2.28 (s, 3 H,  N-CH3), 2.61-2.85 (m, 8 H, H-2’, H-3’, H-
5’, H-6’), 2.91 (dd, J = 6.4 and 10.7 Hz, 1 H, H-4), 3.09 (d, J = 4.0 Hz, 1 H, H-
3), 3.35 (d, J = 3.7 Hz, 1 H, H-2), 3.52 (ddd, J = 0.9, 6.4 and 11 Hz, 1 H, H-5′
), 3.74 (dd, J = 10.7 and 11.0 Hz, 1 H, H-5), 4.56 (d, J = 11.6 Hz, 1 H, 
OCHHPh), 4.80 (d, J = 11.6 Hz, 1 H, OCHHPh), 4.99 (s, 1 H, H-1), 7.28-7.38 
(m, 5 H, C6H5); GASPE NMR (63 MHz, CDCl3): δ = 44.5 (N-CH3), 47.9, 53.8 
(C2’, C3’, C5’, C6’), 48.6, 51.1 (C-2, C-3),54.1 (C-5), 54.4 (C-4), 68.3 
(OCHHPh), 92.5 (C-1), 126.4-127.0, 137.0 (C6H5). FAB-MS: m/z = 305.1 
[M++1]. 
C17H24N2O3 (304.39) 
Calculated C 67.08 H 7.95 N 9.20%, 




Yellow oil; Yield 0.257 g (81%); [α]D20 = +71.1 o (c = 0.44, CH2Cl2): 1H NMR 
(250 MHz, CDCl3): δ = 1.09 (t, J = 7.2 Hz, 3 H, N-CH2CH3), 2.39-2.86 (m, 10 
H, H-2’, H-3’, H-5’, H-6’, N-CH2CH3), 2.91 (dd, J = 6.1 and 10.4 Hz, 1 H, H-
4), 3.10 (d, J = 4.0 Hz, 1 H, H-3), 3.36 (d, J = 3.7 Hz, 1 H, H-2), 3.50 (ddd, J 
= 0.9, 6.4 and 11.0 Hz, 1 H, H-5′), 3.75 (dd, J = 10.7 and11.0 Hz, 1 H, H-5), 




4.99 (s, 1 H, H-1), 7.27-7.70 (m, 5 H, C6H5); GASPE NMR (63 MHz, CDCl3): δ 
= 11.9 (N-CH2CH3), 52.7 (N-CH2CH3), 49.4, 53.0 (C2’, C3’, C5’, C6’), 
50.1,52.3 (C-2, C-3), 55.7 (C-5), 56.0 (C-4), 69.8 (OCHHPh), 94.0 (C-1), 
128.0-128.5, 137.3 (C6H5). FAB-MS: m/z = 319.1 [M++1]. 
C18H26N2O3 (318.42) 
Calculated C 67.908 H 8.23 N 8.80%, 




White solid, m.p. 118-110 oC; Yield 0.315 g (86%); [α]D20 = +67.6 o (c = 0.11, 
CH2Cl2): 1H NMR (250 MHz, CDCl3): δ = 3.07-3.30 (m, 5 H, H-4, H-2’, H-6’), , 
3.41 (d, J = 4.0 Hz, 1 H, H-3), 3.50 (bt, J = 4.6 Hz, 4 H, H-3’, H-5’), 3.70 (bd, 
J = 3.4 Hz, 1 H, H-2), 3.85 (dd, J = 6.1 and 11.0 Hz, 1 H, H-5′), 4.09 (dd, J = 
10.6 and10.7 Hz, 1 H, H-5), 4.58 (d, J = 11.7 Hz, 1 H, OCHHPh), 5.10 (d, J = 
11.6 Hz, 1 H, OCHHPh), 5.28 (s, 1 H, H-1), 6.85-7.39 (m, 10 H, 2 X C6H5); 
GASPE NMR (63 MHz, CDCl3): δ = 49.5, 49.7 (C2’, C3’, C5’, C6’), 50.3, 52.1 
(C-2, C-3),55.7 (C-5), 56.1 (C-4), 70.0 (OCHHPh), 94.1 (C-1), 116.3, 120.1, 
128.1, 129.2, 137.1, 158.2 (2 X C6H5). FAB-MS: m/z = 367.1 [M++1]. 
C22H26N2O3 (366.46) 
Calculated C 72.11 H 7.15 N 7.64%, 





Yellow oil; Yield 0.318 g (83%); [α]D20 = +58.5 o (c = 0.19, CH2Cl2): 1H NMR 
(250 MHz, CDCl3): δ = 2.92-3.17 (m, 10 H, H-3, H-4, H-2’, H-3’, H-5’, H-6’), 
3.47 (bs, 1 H, H-2), 3.60 (dd, J = 5.6 and 11.3 Hz, 1 H, H-5′), 3.86 (dd, J = 
10.1 and10.7 Hz, 1 H, H-5), 4.59 (d, J = 11.9 Hz, 1 H, OCHHPh), 4.83 (d, J = 
11.9 Hz, 1 H, OCHHPh), 5.00 (s, 1 H, H-1), 6.91-7.07 (m, 4 H, C6H5), 7.25-
7.38 (m, 5 H, C6H5); GASPE NMR (63 MHz, CDCl3): δ = 49.8, 50.6 (C2’, C3’, 
C5’, C6’), 50.3, 52.1 (C-2, C-3),55.5 (C-5), 56.2 (C-4), 70.0 (OCHHPh), 94.1 
(C-1), 116.0, 116.3, 119.2, 123.0, 124.5, 128.1-128.6, 137.1, 155.2 (2 X 
C6H5). FAB-MS: m/z = 385.1 [M++1]. 
C22H25FN2O3 (384.45) 
Calculated C 68.73 H 6.55 N 7.29%, 




Yellow solid, m.p. 94-95 oC; Yield 0.301 g (78%); [α]D20 = +67.3 o (c = 0.11, 
CH2Cl2): 1H NMR (250 MHz, CDCl3): δ = 2.74-3.13 (m, 10 H, H-3, H-4, H-2’, 
H-3’, H-5’, H-6’), 3.41 (d, J = 3.7 Hz, 1 H, H-2), 3.57 (ddd, J = 0.91, 6.4 and 
11.3 Hz, 1 H, H-5′), 3.80 (dd, J = 10.5 and10.7 Hz, 1 H, H-5), 4.57 (d, J = 
11.9 Hz, 1 H, OCHHPh), 4.82 (d, J = 11.9 Hz, 1 H, OCHHPh), 5.03 (s, 1 H, H-
1), 6.90-7.00 (m, 4 H, C6H5), 7.31-7.39 (m, 5 H, C6H5); GASPE NMR (63 MHz, 
CDCl3): δ = 49.8, 50.9 (C2’, C3’, C5’, C6’), 50.3, 52.7 (C-2, C-3),55.7 (C-5), 
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56.1 (C-4), 69.9 (OCHHPh), 94.1 (C-1), 116.0, 116.4, 119.2, 122.5, 122.8, 
124.5, , 124.6, 128.0-128.5, 137.3, 153.2, 157.7 (2 X C6H5). FAB-MS: m/z = 
385.1 [M++1]. 
C22H25FN2O3 (384.45) 
Calculated C 68.73 H 6.55 N 7.29%, 




Yellow oil; Yield 0.301 g (78%); [α]D20 = +46.9 o (c = 0.06, CH2Cl2): 1H NMR 
(250 MHz, CDCl3): δ = 2.29 (s, 3 H,  N-CH3), 2.46-2.82 (m, 8 H, H-2’, H-3’, H-
5’, H-6’), 2.92 (brs, 1 H, H-4), 3.34 (m, 2 H, H-2, H-3), 3.66 (d, J = 12.8 Hz, 1 
H, H-5′), 3.86 (dd, J = 3.4 and 12.5 Hz, 1 H, H-5), 4.60 (d, J = 12.6 Hz, 1 H, 
OCHHPh), 4.79 (d, J = 12.2 Hz, 1 H, OCHHPh), 5.01 (d, J = 2.4 Hz, 1 H, H-
1), 7.29-7.40 (m, 5 H, C6H5); GASPE NMR (63 MHz, CDCl3): δ = 46.1 (N-CH3), 
50.3, 55.5 (C2’, C3’, C5’, C6’), 51.1, 51.8 (C-2, C-3),57.0 (C-5), 56.95 (C-4), 
69.1 (OCHHPh), 92.4 (C-1), 127.8-128.5, 137.6 (C6H5). FAB-MS: m/z = 305.1 
[M++1]. 
C17H24N2O3 (304.39) 
Calculated C 67.08 H 7.95 N 9.20%, 







Yellow oil; Yield 0.257 g (81%); [α]D20 = +49.0 o (c = 0.24, CH2Cl2): 1H NMR 
(250 MHz, CDCl3): δ = 1.03 (t, J = 7.2 Hz, 3 H, N-CH2CH3), 2.34-2.78 (m, 10 
H, H-2’, H-3’, H-5’, H-6’, N-CH2CH3), 2.84 (dd, J = 1.5 and 2.2 Hz, 1 H, H-4), 
3.27 (m, 2 H, H-2, H-3), 3.59 (bd, J = 12.5 Hz, 1 H, H-5′), 3.79 (dd, J = 3.4 
and12.5 Hz, 1 H, H-5), 4.53 (d, J = 12.5 Hz, 1 H, OCHHPh), 4.73 (d, J = 12.5 
Hz, 1 H, OCHHPh), 4.93 (d, J = 3.1 Hz, 1 H, H-1), 7.19-7.33 (m, 5 H, C6H5); 
GASPE NMR (63 MHz, CDCl3): δ = 11.8 (N-CH2CH3), 52.3 (N-CH2CH3), 50.2, 
53.2 (C2’, C3’, C5’, C6’), 51.0, 51.8 (C-2, C-3), 57.0 (C-4), 57.5 (C-5), 69.1 
(OCHHPh), 92.4 (C-1), 127.8-128.5, 137.6 (C6H5). FAB-MS: m/z = 319.1 
[M++1]. 
C18H26N2O3 (318.42) 
Calculated C 67.90 H 8.23 N 8.80%, 




Yellow oil; Yield 0.315 g (86%); [α]D20 = +22.1 o (c = 0.12, CH2Cl2): 1H NMR 
(250 MHz, CDCl3): δ = 2.92 (m, 5 H, H-4, H-2’, H-6’), , 3.34 (m, 2 H, H-2, H-
3), 3.34 (br s, 4 H, H-3’, H-5’), 3.67 (d, J = 12.5 Hz, 1 H, H-5′), 3.84 (dd, J = 
3.4 and 12.6 Hz, 1 H, H-5), 4.54 (d, J = 12.2 Hz, 1 H, OCHHPh), 4.74 (d, J = 
12.2 Hz, 1 H, OCHHPh), 4.98 (d, J = 2.7 Hz, 1 H, H-1), 6.84-7.41 (m, 10 H, 2 




51.8 (C-2, C-3), 56.7 (C-5), 57.3 (C-4), 69.2 (OCHHPh), 92.3 (C-1), 116.3, 
120.0, 127.0-129.2, 137.2 (2 X C6H5). FAB-MS: m/z = 367.1 [M++1]. 
C22H26N2O3 (366.46) 
Calculated C 72.11 H 7.15 N 7.64%, 




Yellow solid, m.p. 94-95 oC; Yield 0.318 g (83%); [α]D20 = +36.9 o (c = 0.10, 
CH2Cl2): 1H NMR (250 MHz, CDCl3): δ = 3.00-3.17 (m, 9 H, H-4, H-2’, H-3’, 
H-5’, H-6’), 3.39 (dd, J = 2.9 and 3.1 Hz, 1 H, H-2), 3.48 (bs, 1 H, H-3), 3.77 
(d, J = 13.1 Hz, 1 H, H-5′), 3.92 (dd, J =  3.1 and 12.5 Hz, 1 H, H-5), 4.62 (d, 
J = 12.2 Hz, 1 H, OCHHPh), 4.81 (d, J = 12.2 Hz, 1 H, OCHHPh), 5.05 (d, J = 
2.7 Hz, 1 H, H-1), 6.99-7.10 (m, 4 H, C6H5), 7.28-7.41 (m, 5 H, C6H5); GASPE 
NMR (63 MHz, CDCl3): δ = 50.7 (C2’, C3’, C5’, C6’), 51.9, 55.1 (C-2, C-3),56.2 
(C-5), 57.1 (C-4), 69.9 (OCHHPh), 92.3 (C-1), 116.0, 119.2, 124.5, 127.9-
128.5, 137.1 (2 X C6H5). FAB-MS: m/z = 385.1 [M++1]. 
C22H25FN2O3 (384.45) 
Calculated C 68.73 H 6.55 N 7.29%, 








Yellow solid, m.p. 111-112 oC; Yield 0.301 g (78%); [α]D20 = +34.0 o (c = 0.36, 
CH2Cl2): 1H NMR (250 MHz, CDCl3): δ = 2.94-3.15 (m, 9 H, H-4, H-2’, H-3’, 
H-5’, H-6’), 3.38 (m, 2 H, H-2, H-3), 3.74 (bd, J = 11.3 Hz, 1 H, H-5′), 3.92 
(bd, J = 11.3 Hz, 1 H, H-5), 4.61 (d, J = 12.2 Hz, 1 H, OCHHPh), 4.81 (d, J = 
12.2 Hz, 1 H, OCHHPh), 5.05 (d, J = 3.1 Hz, 1 H, H-1), 6.84-7.00 (m, 4 H, 
C6H5), 7.28-7.41 (m, 5 H, C6H5); GASPE NMR (63 MHz, CDCl3): δ = 50.6 (C2’, 
C3’, C5’, C6’), 54.5 (C-2, C-3), 55.7 (C-5), 56.1 (C-4), 69.2 (OCHHPh), 92.1 
(C-1), 116.0-128.5, 137.3, 155.1 157.7 (2 X C6H5). FAB-MS: m/z = 385.1 
[M++1]. 
C22H25FN2O3 (384.45) 
Calculated C 68.73 H 6.55 N 7.29%, 










This thesis describes the application of carbohydrates as “chiral synthons” 
for the stereoselective syntheses of, both, natural products and new 
synthetic classes of compounds. Combination of the natural chirality and 
inherent topology of cyclic sugar derivatives allowed to design a strategy for 
the enantio-selective total synthesis of α, β−unsaturated δ-lactones. 
In chapter I, a facile total synthesis of the non-natural S-(+)-argentilactone 
has been achieved, starting from methyl α-D-glucopyranoside. 2,3-Dideoxy-
genation of the benzylidene acetal was followed by the deprotection of the 
benzylidene group and selective protection of the resulting diol at primary 
position. The secondary alcohol was mesylated and reductively displaced 
with Supehydride®. Swern oxidation and then Wittig reaction introduced the 
desired side chain. Finally, the anomeric position was oxidized with catalytic 
amounts of MoO3 to furnish the target argentilactone.  
Chapter II involved the total syntheses of massoilactone and O-acetyl 
osmundalctone, both naturally occurring α, β−unsaturated δ-lactones. The 
benzylidene acetal, produced from methyl α-D-glucopyranoside, was stereo-
selectively opened under the conditions developed by Hanessian. The 
resulting 6-bromodiol was subjected to 2,3-dideoxygenation with 2,4,5-
triiodoimidazole. Nucleophilic displacement with lithium dibutyl cuprate (for 
massoilactone) and Superhydride® (for osmundalactone) generated the inter-
mediates that were further manipulated for the total syntheses of the 
respective natural products. 
In chapter III, the total synthesis of naturally occurring argentilactone is 
presented, following a different approach. The furanglycol, prepared from D-
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glucal, was subjected to the Mitsunobu reaction for the inversion of the 
configuration. The benzoyl group was removed from the secondary position 
of the furan derivative after protection of the free primary alcohol, and the 
resulting monoalcohol underwent oxidative rearrangement with NBS to 
furnish the L-hexenulose. The anomeric position was blocked and the keto 
group reduced to produce the partially protected allylic alcohol. After 
mesylation, a similar sequence of reactions was followed as is described in 
chapter I for S-(+)-argentilactone. The synthetic argentilactone was tested in 
vitro against Leishmania mexicana. Chapter IV describes preliminary results 
of a biological study. 
In chapter VI, an efficient and one pot reaction for the synthesis of 1,4,5,6-
tetrahydro-[1,2,4]triazine is described. The in situ-generated nitrilimines from 
the corresponding hydrazonoyl chlorides reacted readily with benzyl 4-
amino-4-deoxy-2,3-anhydro-lyxopyranosides to furnish chiral triazines in 
good to excellent yields. 
Chapter VII presents examples for the syntheses of chiral cyclic 
trithiocarbonates from the triflates of 2,3- and 3,4-anhydropentopyrano-
sides. Sodium trithiocarbonate, prepared from Na2S and CS2, undergoes a 
nucleophilic displacement of the triflyl group, followed by a simultaneous 
ring opening reaction of the epoxide to produce 5- and 6-membered cyclic 
trithiocarbonates in good yield. 
In chapter VIII, a selected set of 4-(4-substituted-1-piperazinyl)-anhydro-
lyxopyranosides were prepared for biological testing. In the present form they 




Im Rahmen der hier vorliegenden Arbeit wurden Kohlehydrate als “chirale  
Synthone” für die stereoselektive Synthese von Naturstoffen sowie neuen 
synthetischen Substanzklassen verwendet. Die Kombination von natürlicher 
Chiralität mit der Topologie eines cyclischen Zuckerderivats erlaubte eine 
Strategie zur enantioselectiven Totalsynthese von α, β−ungesättigten δ-
Lactonen zu entwickeln. 
In Kapital I dieser Arbeit wird eine Totalsynthese des nicht natürlichen S-(+)-
Argentilactons, ausgehend von Methyl-α-D-glucopyranosid, vorgestellt. Nach 
der 2,3-Didesoxyenierung vom Benzylidenacetal und Abspaltung der 
Benzylidenschutzgruppe wird das resultierende Diol an der 1-Position 
selektiv geschützt. Der sekundäre Alkohol wird mesyliert und anschließend 
durch “Superhydrid” entfernt. Eine Swern-Oxidation mit anschließender 
Wittig-Reaktion führt die Seitenkette ein. Anschließend wird die anomere 
Funktion mit katalytischen Mengen MoO3 oxidiert, um schließlich das 
Zielmoleküle Argentilacton zu erhalten. 
Kapital II beschreibt die Totalsynthese von Massoilacton und O-Acetyl-
Osmundalacton, beides sind natürlicher vorkommende α, β-ungesättigte δ− 
Lactone. Das Benzylidenacetal, aus Methyl-α-D-glucopyranosid synthetiziert, 
wird stereoselektiv unter Hanessian-Bedingungen geöffnet. Das resultierende 
6-Bromdiol wird mit 2.4.5-Triiodoimidazol didesoxigeniert. Nukleophile 
Verdrängung mit Lithiumdibutylcuprat (für Massoilacton) bzw. Superhydrid 
(für Osmundalacton) generieren die Zwischenprodukte, die für die 
Totalsynthese dieser Naturstoffe benötigt werden. 
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In Kapitel III wird die Totalsynthese  von natürlich vorkommenden 
Argentilacton präsentiert. Das Furanglykol, aus D-Glucal synthesiert, wird 
einer Mitsunobu-Reaktion unterzogen, um eine Umkehr der Konfiguration 
zu erzielen. Die Benzoylgruppe an der sekundären Position des 
Furanderivates wird entfernt, nachdem die freie primäre Alkoholfunktion 
geschützt wurde. Der resultierende Monoalkohol wird einer oxidativen 
Umlagerung mit N-Bromsuccinimid unterzogen, um schließlich zur L-
Hexenulose zu gelangen. Die anomere Position wird blockiert, die 
Ketogruppe reduziert, um so einen partialgeschützten allylischen Alkohol zu 
erhalten. Nach erfolgter Mesylierung folgt eine ähnliche Sequenz von 
Reaktionen wie in Kapitel I für das (+)-Argentilaction beschrieben. Das 
synthetische (-)-Argentilacton wurde in vitro gegen Leishmania mexicana 
getestet. Kapitel IV beschreibt die vorläufigen Ergebnisse dieser biologischen 
Studie. 
In Kapitel VI wird eine effiziente 1-Stufenreaktion für die Synthese von 
1.4.5.6-Tetrahydro-[1.2.4]triazinen beschrieben. Das in situ generierte 
Nitrilimin reagiert direkt mit Benzyl-4-amino-4-desoxy-2,3-anydro-
lyxopyranosid, um so das chirale Triazin in guten Ausbauter zu ergeben. 
Kapital VII präsentiert die Synthese chiraler cyclischer Trithiocarbonate aus 
den Triflaten der 2,3- bzw. 3,4-Anhydropentopyranoside. Natrium-
trithiocarbonat, aus Na2S und CS2 dargestellt, substituiert die Triflatgruppe 
unter gleichzeitiger simultaner Ringöffnung des Epoxids, um 5- bzw. 6- 
gliedrige cyclische Trithiocarbonate zu bilden. 
In Kapitel VIII werden eine Reihe von 4-(4-substituierte-1-piperazinyl)-
anhydrolyxcopyranoside synthetisiert, um deren biologische Aktivitat zu 
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testen. Obwohl keines dieser neuen Derivate eine signifikante Aktivität gegen 
Bakterien und Pilze zeigte, sollte die CNS-Wirkung noch untersucht werden. 
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